Disorder (of)

Alphabetical Index

Use the alphabetical index for the main term disorder (of) to review the available sub terms and properly select the ICD-10 code with the highest degree of specificity. Instructional notations will guide the coder with information such as "see", "see also", "with", "without", "due to", and "code by site".

  • Disorder (of) - See Also: Disease;
    • acantholytic - L11.9 Acantholytic disorder, unspecified
      • specified NEC - L11.8 Other specified acantholytic disorders
    • acute
      • psychotic - See: Psychosis, acute;
      • stress - F43.0 Acute stress reaction
    • adjustment (grief) - F43.20 Adjustment disorder, unspecified
      • with
        • anxiety - F43.22 Adjustment disorder with anxiety
          • with depressed mood - F43.23 Adjustment disorder with mixed anxiety and depressed mood
        • conduct disturbance - F43.24 Adjustment disorder with disturbance of conduct
          • with emotional disturbance - F43.25 Adjustment disorder with mixed disturbance of emotions and conduct
        • depressed mood - F43.21 Adjustment disorder with depressed mood
          • with anxiety - F43.23 Adjustment disorder with mixed anxiety and depressed mood
        • other specified symptom - F43.29 Adjustment disorder with other symptoms
    • adrenal (capsule) (gland) (medullary) - E27.9 Disorder of adrenal gland, unspecified
      • specified NEC - E27.8 Other specified disorders of adrenal gland
    • adrenogenital - E25.9 Adrenogenital disorder, unspecified
      • drug-induced - E25.8 Other adrenogenital disorders
      • iatrogenic - E25.8 Other adrenogenital disorders
      • idiopathic - E25.8 Other adrenogenital disorders
    • adult personality (and behavior) - F69 Unspecified disorder of adult personality and behavior
      • specified NEC - F68.8 Other specified disorders of adult personality and behavior
    • affective (mood) - See: Disorder, mood;
    • aggressive, unsocialized - F91.1 Conduct disorder, childhood-onset type
    • alcohol use
      • mild - F10.10 Alcohol abuse, uncomplicated
        • in remission (early) (sustained) - F10.11 Alcohol abuse, in remission
        • with
          • alcohol intoxication - F10.129 Alcohol abuse with intoxication, unspecified
            • delirium - F10.121 Alcohol abuse with intoxication delirium
          • alcohol-induced
            • anxiety disorder - F10.180 Alcohol abuse with alcohol-induced anxiety disorder
            • depressive disorder - F10.14 Alcohol abuse with alcohol-induced mood disorder
            • psychotic disorder - F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified
            • sexual dysfunction - F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
            • sleep disorder - F10.182 Alcohol abuse with alcohol-induced sleep disorder
      • moderate or severe - F10.20 Alcohol dependence, uncomplicated
        • in remission (early) (sustained) - F10.21 Alcohol dependence, in remission
        • with
          • alcohol intoxication - F10.229 Alcohol dependence with intoxication, unspecified
            • delirium - F10.221 Alcohol dependence with intoxication delirium
          • alcohol-induced
            • anxiety disorder - F10.280 Alcohol dependence with alcohol-induced anxiety disorder
            • depressive disorder - F10.24 Alcohol dependence with alcohol-induced mood disorder
            • major neurocognitive disorder, amnestic-confabulatory type - F10.26 Alcohol dependence with alcohol-induced persisting amnestic disorder
            • major neurocognitive disorder, nonamnestic-confabulatory type - F10.27 Alcohol dependence with alcohol-induced persisting dementia
            • mild neurocognitive disorder - F10.288 Alcohol dependence with other alcohol-induced disorder
            • psychotic disorder - F10.259 Alcohol dependence with alcohol-induced psychotic disorder, unspecified
            • sexual dysfunction - F10.281 Alcohol dependence with alcohol-induced sexual dysfunction
            • sleep disorder - F10.282 Alcohol dependence with alcohol-induced sleep disorder
    • allergic - See: Allergy;
    • alveolar NEC - J84.09 Other alveolar and parieto-alveolar conditions
    • amino-acid
      • cystathioninuria - E72.19 Other disorders of sulfur-bearing amino-acid metabolism
      • cystinosis - E72.04 Cystinosis
      • cystinuria - E72.01 Cystinuria
      • glycinuria - E72.09 Other disorders of amino-acid transport
      • homocystinuria - E72.11 Homocystinuria
      • metabolism - See: Disturbance, metabolism, amino-acid;
        • specified NEC - E72.89 Other specified disorders of amino-acid metabolism
      • neonatal, transitory - P74.8 Other transitory metabolic disturbances of newborn
      • renal transport NEC - E72.09 Other disorders of amino-acid transport
      • transport NEC - E72.09 Other disorders of amino-acid transport
    • amnesic, amnestic
      • alcohol-induced - F10.96 Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
        • with dependence - F10.26 Alcohol dependence with alcohol-induced persisting amnestic disorder
      • due to (secondary to) general medical condition - F04 Amnestic disorder due to known physiological condition
      • psychoactive NEC-induced - F19.96 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
        • with
          • abuse - F19.16 Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
          • dependence - F19.26 Other psychoactive substance dependence with psychoactive substance-induced persisting amnestic disorder
      • sedative, hypnotic or anxiolytic-induced - F13.96 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
        • with dependence - F13.26 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
    • amphetamine (or other stimulant) use
      • mild
        • with
          • amphetamine (or other stimulant)-induced
            • anxiety disorder - F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
            • depressive disorder - F15.14 Other stimulant abuse with stimulant-induced mood disorder
            • psychotic disorder - F15.159 Other stimulant abuse with stimulant-induced psychotic disorder, unspecified
            • sexual dysfunction - F15.181 Other stimulant abuse with stimulant-induced sexual dysfunction
          • amphetamine, cocaine, or other stimulant intoxication
            • with perceptual disturbances - F15.122 Other stimulant abuse with intoxication with perceptual disturbance
            • without perceptual disturbances - F15.129 Other stimulant abuse with intoxication, unspecified
          • intoxication delirium - F15.121 Other stimulant abuse with intoxication delirium
      • moderate or severe
        • with
          • amphetamine (or other stimulant)-induced
            • anxiety disorder - F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
            • depressive disorder - F15.24 Other stimulant dependence with stimulant-induced mood disorder
            • psychotic disorder - F15.259 Other stimulant dependence with stimulant-induced psychotic disorder, unspecified
            • sexual dysfunction - F15.281 Other stimulant dependence with stimulant-induced sexual dysfunction
          • amphetamine, cocaine, or other stimulant intoxication
            • with perceptual disturbances - F15.222 Other stimulant dependence with intoxication with perceptual disturbance
            • without perceptual disturbances - F15.229 Other stimulant dependence with intoxication, unspecified
          • intoxication delirium - F15.221 Other stimulant dependence with intoxication delirium
    • amphetamine-type substance use
      • mild - F15.10 Other stimulant abuse, uncomplicated
        • in remission (early) (sustained) - F15.11 Other stimulant abuse, in remission
      • moderate - F15.20 Other stimulant dependence, uncomplicated
        • in remission (early) (sustained) - F15.21 Other stimulant dependence, in remission
      • severe - F15.20 Other stimulant dependence, uncomplicated
        • in remission (early) (sustained) - F15.21 Other stimulant dependence, in remission
    • anaerobic glycolysis with anemia - D55.2 Anemia due to disorders of glycolytic enzymes
    • anxiety - F41.9 Anxiety disorder, unspecified
      • due to (secondary to)
        • alcohol - F10.980 Alcohol use, unspecified with alcohol-induced anxiety disorder
          • in
            • abuse - F10.180 Alcohol abuse with alcohol-induced anxiety disorder
            • dependence - F10.280 Alcohol dependence with alcohol-induced anxiety disorder
        • amphetamine - F15.980 Other stimulant use, unspecified with stimulant-induced anxiety disorder
          • in
            • abuse - F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
            • dependence - F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
        • anxiolytic - F13.980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
          • in
            • abuse - F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
            • dependence - F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
        • caffeine - F15.980 Other stimulant use, unspecified with stimulant-induced anxiety disorder
          • in
            • abuse - F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
            • dependence - F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
        • cannabis - F12.980 Cannabis use, unspecified with anxiety disorder
          • in
            • abuse - F12.180 Cannabis abuse with cannabis-induced anxiety disorder
            • dependence - F12.280 Cannabis dependence with cannabis-induced anxiety disorder
        • cocaine - F14.980 Cocaine use, unspecified with cocaine-induced anxiety disorder
          • in
            • abuse - F14.180 Cocaine abuse with cocaine-induced anxiety disorder
            • dependence - F14.180 Cocaine abuse with cocaine-induced anxiety disorder
        • general medical condition - F06.4 Anxiety disorder due to known physiological condition
        • hallucinogen - F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
          • in
            • abuse - F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
            • dependence - F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
        • hypnotic - F13.980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
          • in
            • abuse - F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
            • dependence - F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
        • inhalant - F18.980 Inhalant use, unspecified with inhalant-induced anxiety disorder
          • in
            • abuse - F18.180 Inhalant abuse with inhalant-induced anxiety disorder
            • dependence - F18.280 Inhalant dependence with inhalant-induced anxiety disorder
        • phencyclidine - F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
          • in
            • abuse - F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
            • dependence - F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
        • psychoactive substance NEC - F19.980 Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder
          • in
            • abuse - F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
            • dependence - F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
        • sedative - F13.980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
          • in
            • abuse - F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
            • dependence - F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
        • volatile solvents - F18.980 Inhalant use, unspecified with inhalant-induced anxiety disorder
          • in
            • abuse - F18.180 Inhalant abuse with inhalant-induced anxiety disorder
            • dependence - F18.280 Inhalant dependence with inhalant-induced anxiety disorder
      • generalized - F41.1 Generalized anxiety disorder
      • illness - F45.21 Hypochondriasis
      • mixed
        • specified NEC - F41.3 Other mixed anxiety disorders
        • with depression (mild) - F41.8 Other specified anxiety disorders
      • organic - F06.4 Anxiety disorder due to known physiological condition
      • phobic - F40.9 Phobic anxiety disorder, unspecified
        • of childhood - F40.8 Other phobic anxiety disorders
      • specified NEC - F41.8 Other specified anxiety disorders
    • aortic valve - See: Endocarditis, aortic;
    • aromatic amino-acid metabolism - E70.9 Disorder of aromatic amino-acid metabolism, unspecified
      • specified NEC - E70.8 Other disorders of aromatic amino-acid metabolism
    • arteriole NEC - I77.89 Other specified disorders of arteries and arterioles
    • artery NEC - I77.89 Other specified disorders of arteries and arterioles
    • articulation - See: Disorder, joint;
    • attachment (childhood)
      • disinhibited - F94.2 Disinhibited attachment disorder of childhood
      • reactive - F94.1 Reactive attachment disorder of childhood
    • attention-deficit hyperactivity (adolescent) (adult) (child) - F90.9 Attention-deficit hyperactivity disorder, unspecified type
      • combined
        • presentation - F90.2 Attention-deficit hyperactivity disorder, combined type
        • type - F90.2 Attention-deficit hyperactivity disorder, combined type
      • hyperactive
        • impulsive presentation - F90.1 Attention-deficit hyperactivity disorder, predominantly hyperactive type
        • type - F90.1 Attention-deficit hyperactivity disorder, predominantly hyperactive type
      • inattentive
        • presentation - F90.0 Attention-deficit hyperactivity disorder, predominantly inattentive type
        • type - F90.0 Attention-deficit hyperactivity disorder, predominantly inattentive type
      • specified type NEC - F90.8 Attention-deficit hyperactivity disorder, other type
    • attention-deficit without hyperactivity (adolescent) (adult) (child) - F98.8 Other specified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
    • auditory processing (central) - H93.25 Central auditory processing disorder
    • autism spectrum - F84.0 Autistic disorder
    • autistic - F84.0 Autistic disorder
    • autoimmune - D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified
    • autonomic nervous system - G90.9 Disorder of the autonomic nervous system, unspecified
      • specified NEC - G90.8 Other disorders of autonomic nervous system
    • avoidant
      • child or adolescent - F40.10 Social phobia, unspecified
      • restrictive food intake - F50.82 Avoidant/restrictive food intake disorder
    • balance
      • acid-base - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
        • mixed - E87.4 Mixed disorder of acid-base balance
      • electrolyte - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
      • fluid NEC - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
    • behavioral (disruptive) - See: Disorder, conduct;
    • beta-amino-acid metabolism - E72.89 Other specified disorders of amino-acid metabolism
    • bile acid and cholesterol metabolism - E78.70 Disorder of bile acid and cholesterol metabolism, unspecified
      • Barth syndrome - E78.71 Barth syndrome
      • other specified - E78.79 Other disorders of bile acid and cholesterol metabolism
      • Smith-Lemli-Opitz syndrome - E78.72 Smith-Lemli-Opitz syndrome
    • bilirubin excretion - E80.6 Other disorders of bilirubin metabolism
    • binge eating - F50.81 Binge eating disorder
    • binocular
      • movement - H51.9 Unspecified disorder of binocular movement
        • convergence
          • excess - H51.12 Convergence excess
          • insufficiency - H51.11 Convergence insufficiency
        • internuclear ophthalmoplegia - See: Ophthalmoplegia, internuclear;
        • palsy of conjugate gaze - H51.0 Palsy (spasm) of conjugate gaze
        • specified type NEC - H51.8 Other specified disorders of binocular movement
      • vision NEC - See: Disorder, vision, binocular;
    • bipolar (I) (type 1) - F31.9 Bipolar disorder, unspecified
      • current (or most recent) episode
        • depressed - F31.9 Bipolar disorder, unspecified
          • with psychotic features - F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features
          • without psychotic features - F31.30 Bipolar disorder, current episode depressed, mild or moderate severity, unspecified
            • mild - F31.31 Bipolar disorder, current episode depressed, mild
            • moderate - F31.32 Bipolar disorder, current episode depressed, moderate
            • severe (without psychotic features) - F31.4 Bipolar disorder, current episode depressed, severe, without psychotic features
              • with psychotic features - F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features
        • hypomanic - F31.0 Bipolar disorder, current episode hypomanic
        • manic - F31.9 Bipolar disorder, unspecified
          • with psychotic features - F31.2 Bipolar disorder, current episode manic severe with psychotic features
          • without psychotic features - F31.10 Bipolar disorder, current episode manic without psychotic features, unspecified
            • mild - F31.11 Bipolar disorder, current episode manic without psychotic features, mild
            • moderate - F31.12 Bipolar disorder, current episode manic without psychotic features, moderate
            • severe (without psychotic features) - F31.13 Bipolar disorder, current episode manic without psychotic features, severe
              • with psychotic features - F31.2 Bipolar disorder, current episode manic severe with psychotic features
        • mixed - F31.60 Bipolar disorder, current episode mixed, unspecified
          • mild - F31.61 Bipolar disorder, current episode mixed, mild
          • moderate - F31.62 Bipolar disorder, current episode mixed, moderate
          • severe (without psychotic features) - F31.63 Bipolar disorder, current episode mixed, severe, without psychotic features
            • with psychotic features - F31.64 Bipolar disorder, current episode mixed, severe, with psychotic features
        • severe depression (without psychotic features) - F31.4 Bipolar disorder, current episode depressed, severe, without psychotic features
          • with psychotic features - F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features
      • II (type 2) - F31.81 Bipolar II disorder
      • in remission (currently) - F31.70 Bipolar disorder, currently in remission, most recent episode unspecified
        • in full remission
          • most recent episode
            • depressed - F31.76 Bipolar disorder, in full remission, most recent episode depressed
            • hypomanic - F31.72 Bipolar disorder, in full remission, most recent episode hypomanic
            • manic - F31.74 Bipolar disorder, in full remission, most recent episode manic
            • mixed - F31.78 Bipolar disorder, in full remission, most recent episode mixed
        • in partial remission
          • most recent episode
            • depressed - F31.75 Bipolar disorder, in partial remission, most recent episode depressed
            • hypomanic - F31.71 Bipolar disorder, in partial remission, most recent episode hypomanic
            • manic - F31.73 Bipolar disorder, in partial remission, most recent episode manic
            • mixed - F31.77 Bipolar disorder, in partial remission, most recent episode mixed
      • organic - F06.30 Mood disorder due to known physiological condition, unspecified
      • single manic episode - F30.9 Manic episode, unspecified
        • mild - F30.11 Manic episode without psychotic symptoms, mild
        • moderate - F30.12 Manic episode without psychotic symptoms, moderate
        • severe (without psychotic symptoms) - F30.13 Manic episode, severe, without psychotic symptoms
          • with psychotic symptoms - F30.2 Manic episode, severe with psychotic symptoms
      • specified NEC - F31.89 Other bipolar disorder
    • bladder - N32.9 Bladder disorder, unspecified
      • functional NEC - N31.9 Neuromuscular dysfunction of bladder, unspecified
      • in schistosomiasis - B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis]
      • specified NEC - N32.89 Other specified disorders of bladder
    • bleeding - D68.9 Coagulation defect, unspecified
    • blood - D75.9 Disease of blood and blood-forming organs, unspecified
      • in congenital early syphilis - A50.09 Other early congenital syphilis, symptomatic
    • body dysmorphic - F45.22 Body dysmorphic disorder
    • bone - M89.9 Disorder of bone, unspecified
      • continuity - M84.9 Disorder of continuity of bone, unspecified
        • specified type NEC - M84.80 Other disorders of continuity of bone, unspecified site
          • ankle - M84.87 Other disorders of continuity of bone, ankle and foot
          • fibula - M84.86 Other disorders of continuity of bone, tibia and fibula
          • foot - M84.87 Other disorders of continuity of bone, ankle and foot
          • hand - M84.84 Other disorders of continuity of bone, hand
          • humerus - M84.82 Other disorders of continuity of bone, humerus
          • neck - M84.88 Other disorders of continuity of bone, other site
          • pelvis - M84.859 Other disorders of continuity of bone, unspecified pelvic region and thigh
          • radius - M84.83 Other disorders of continuity of bone, ulna and radius
          • rib - M84.88 Other disorders of continuity of bone, other site
          • shoulder - M84.81 Other disorders of continuity of bone, shoulder
          • skull - M84.88 Other disorders of continuity of bone, other site
          • thigh - M84.85 Other disorders of continuity of bone, pelvic region and thigh
          • tibia - M84.86 Other disorders of continuity of bone, tibia and fibula
          • ulna - M84.83 Other disorders of continuity of bone, ulna and radius
          • vertebra - M84.88 Other disorders of continuity of bone, other site
      • density and structure - M85.9 Disorder of bone density and structure, unspecified
        • cyst - See Also: Cyst, bone, specified type NEC;
          • aneurysmal - See: Cyst, bone, aneurysmal;
          • solitary - See: Cyst, bone, solitary;
        • diffuse idiopathic skeletal hyperostosis - See: Hyperostosis, ankylosing;
        • fibrous dysplasia (monostotic) - See: Dysplasia, fibrous, bone;
        • fluorosis - See: Fluorosis, skeletal;
        • hyperostosis of skull - M85.2 Hyperostosis of skull
        • osteitis condensans - See: Osteitis, condensans;
        • specified type NEC - M85.8 Other specified disorders of bone density and structure
          • ankle - M85.87 Other specified disorders of bone density and structure, ankle and foot
          • foot - M85.87 Other specified disorders of bone density and structure, ankle and foot
          • forearm - M85.83 Other specified disorders of bone density and structure, forearm
          • hand - M85.84 Other specified disorders of bone density and structure, hand
          • lower leg - M85.86 Other specified disorders of bone density and structure, lower leg
          • multiple sites - M85.89 Other specified disorders of bone density and structure, multiple sites
          • neck - M85.88 Other specified disorders of bone density and structure, other site
          • rib - M85.88 Other specified disorders of bone density and structure, other site
          • shoulder - M85.81 Other specified disorders of bone density and structure, shoulder
          • skull - M85.88 Other specified disorders of bone density and structure, other site
          • thigh - M85.85 Other specified disorders of bone density and structure, thigh
          • upper arm - M85.82 Other specified disorders of bone density and structure, upper arm
          • vertebra - M85.88 Other specified disorders of bone density and structure, other site
      • development and growth NEC - M89.20 Other disorders of bone development and growth, unspecified site
        • carpus - M89.24 Other disorders of bone development and growth, hand
        • clavicle - M89.21 Other disorders of bone development and growth, shoulder
        • femur - M89.25 Other disorders of bone development and growth, femur
        • fibula - M89.26 Other disorders of bone development and growth, tibia and fibula
        • finger - M89.24 Other disorders of bone development and growth, hand
        • humerus - M89.22 Other disorders of bone development and growth, humerus
        • ilium - M89.259 Other disorders of bone development and growth, unspecified femur
        • ischium - M89.259 Other disorders of bone development and growth, unspecified femur
        • metacarpus - M89.24 Other disorders of bone development and growth, hand
        • metatarsus - M89.27 Other disorders of bone development and growth, ankle and foot
        • multiple sites - M89.29 Other disorders of bone development and growth, multiple sites
        • neck - M89.28 Other disorders of bone development and growth, other site
        • radius - M89.23 Other disorders of bone development and growth, ulna and radius
        • rib - M89.28 Other disorders of bone development and growth, other site
        • scapula - M89.21 Other disorders of bone development and growth, shoulder
        • skull - M89.28 Other disorders of bone development and growth, other site
        • tarsus - M89.27 Other disorders of bone development and growth, ankle and foot
        • tibia - M89.26 Other disorders of bone development and growth, tibia and fibula
        • toe - M89.27 Other disorders of bone development and growth, ankle and foot
        • ulna - M89.23 Other disorders of bone development and growth, ulna and radius
        • vertebra - M89.28 Other disorders of bone development and growth, other site
      • specified type NEC - M89.8X Other specified disorders of bone
    • brachial plexus - G54.0 Brachial plexus disorders
    • branched-chain amino-acid metabolism - E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
      • specified NEC - E71.19 Other disorders of branched-chain amino-acid metabolism
    • breast - N64.9 Disorder of breast, unspecified
      • agalactia - See: Agalactia;
      • associated with
        • lactation - O92.70 Unspecified disorders of lactation
          • specified NEC - O92.79 Other disorders of lactation
        • pregnancy - O92.20 Unspecified disorder of breast associated with pregnancy and the puerperium
          • specified NEC - O92.29 Other disorders of breast associated with pregnancy and the puerperium
        • puerperium - O92.20 Unspecified disorder of breast associated with pregnancy and the puerperium
          • specified NEC - O92.29 Other disorders of breast associated with pregnancy and the puerperium
      • cracked nipple - See: Cracked nipple;
      • galactorrhea - See: Galactorrhea;
      • hypogalactia - O92.4 Hypogalactia
      • lactation disorder NEC - O92.79 Other disorders of lactation
      • mastitis - See: Mastitis;
      • nipple infection - See: Infection, nipple;
      • retracted nipple - See: Retraction, nipple;
      • specified type NEC - N64.89 Other specified disorders of breast
    • Briquet's - F45.0 Somatization disorder
    • bullous, in diseases classified elsewhere - L14 Bullous disorders in diseases classified elsewhere
    • caffeine use
      • mild
        • with
          • caffeine-induced
            • anxiety disorder - F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
            • sleep disorder - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
      • moderate or severe
        • with
          • caffeine-induced
            • anxiety disorder - F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
            • sleep disorder - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
    • cannabis use
      • mild - F12.10 Cannabis abuse, uncomplicated
        • in remission (early) (sustained) - F12.11 Cannabis abuse, in remission
        • with
          • cannabis intoxication delirium - F12.121 Cannabis abuse with intoxication delirium
            • with perceptual disturbances - F12.122 Cannabis abuse with intoxication with perceptual disturbance
            • without perceptual disturbances - F12.129 Cannabis abuse with intoxication, unspecified
          • cannabis-induced
            • anxiety disorder - F12.180 Cannabis abuse with cannabis-induced anxiety disorder
            • psychotic disorder - F12.159 Cannabis abuse with psychotic disorder, unspecified
            • sleep disorder - F12.188 Cannabis abuse with other cannabis-induced disorder
      • moderate or severe - F12.20 Cannabis dependence, uncomplicated
        • in remission (early) (sustained) - F12.21 Cannabis dependence, in remission
        • with
          • cannabis intoxication
            • with perceptual disturbances - F12.222 Cannabis dependence with intoxication with perceptual disturbance
            • without perceptual disturbances - F12.229 Cannabis dependence with intoxication, unspecified
          • cannabis-induced
            • anxiety disorder - F12.280 Cannabis dependence with cannabis-induced anxiety disorder
            • psychotic disorder - F12.259 Cannabis dependence with psychotic disorder, unspecified
            • sleep disorder - F12.288 Cannabis dependence with other cannabis-induced disorder
          • delirium - F12.221 Cannabis dependence with intoxication delirium
    • carbohydrate
      • absorption, intestinal NEC - E74.39 Other disorders of intestinal carbohydrate absorption
      • metabolism (congenital) - E74.9 Disorder of carbohydrate metabolism, unspecified
        • specified NEC - E74.8 Other specified disorders of carbohydrate metabolism
    • cardiac, functional - I51.89 Other ill-defined heart diseases
    • carnitine metabolism - E71.40 Disorder of carnitine metabolism, unspecified
    • cartilage - M94.9 Disorder of cartilage, unspecified
      • articular NEC - See: Derangement, joint, articular cartilage;
        • chondrocalcinosis - See: Chondrocalcinosis;
      • specified type NEC - M94.8X Other specified disorders of cartilage
        • articular - See: Derangement, joint, articular cartilage;
        • multiple sites - M94.8X0 Other specified disorders of cartilage, multiple sites
    • catatonia (due to known physiological condition) (with another mental disorder) - F06.1 Catatonic disorder due to known physiological condition
    • catatonic
      • due to (secondary to) known physiological condition - F06.1 Catatonic disorder due to known physiological condition
      • organic - F06.1 Catatonic disorder due to known physiological condition
    • central auditory processing - H93.25 Central auditory processing disorder
    • cervical
      • region NEC - M53.82 Other specified dorsopathies, cervical region
      • root (nerve) NEC - G54.2 Cervical root disorders, not elsewhere classified
    • character NOS - F60.9 Personality disorder, unspecified
    • childhood disintegrative NEC - F84.3 Other childhood disintegrative disorder
    • cholesterol and bile acid metabolism - E78.70 Disorder of bile acid and cholesterol metabolism, unspecified
      • Barth syndrome - E78.71 Barth syndrome
      • other specified - E78.79 Other disorders of bile acid and cholesterol metabolism
      • Smith-Lemli-Opitz syndrome - E78.72 Smith-Lemli-Opitz syndrome
    • choroid - H31.9 Unspecified disorder of choroid
      • atrophy - See: Atrophy, choroid;
      • degeneration - See: Degeneration, choroid;
      • detachment - See: Detachment, choroid;
      • dystrophy - See: Dystrophy, choroid;
      • hemorrhage - See: Hemorrhage, choroid;
      • rupture - See: Rupture, choroid;
      • scar - See: Scar, chorioretinal;
      • solar retinopathy - See: Retinopathy, solar;
      • specified type NEC - H31.8 Other specified disorders of choroid
    • ciliary body - See: Disorder, iris;
      • degeneration - See: Degeneration, ciliary body;
    • coagulation (factor) - See Also: Defect, coagulation; - D68.9 Coagulation defect, unspecified
      • newborn, transient - P61.6 Other transient neonatal disorders of coagulation
    • cocaine use
      • mild - F14.10 Cocaine abuse, uncomplicated
        • in remission (early) (sustained) - F14.11 Cocaine abuse, in remission
        • with
          • amphetamine, cocaine, or other stimulant intoxication
            • with perceptual disturbances - F14.122 Cocaine abuse with intoxication with perceptual disturbance
            • without perceptual disturbances - F14.129 Cocaine abuse with intoxication, unspecified
          • cocaine intoxication delirium - F14.121 Cocaine abuse with intoxication with delirium
          • cocaine-induced
            • anxiety disorder - F14.180 Cocaine abuse with cocaine-induced anxiety disorder
            • depressive disorder - F14.14 Cocaine abuse with cocaine-induced mood disorder
            • psychotic disorder - F14.159 Cocaine abuse with cocaine-induced psychotic disorder, unspecified
            • sexual dysfunction - F14.181 Cocaine abuse with cocaine-induced sexual dysfunction
            • sleep disorder - F14.182 Cocaine abuse with cocaine-induced sleep disorder
      • moderate or severe - F14.20 Cocaine dependence, uncomplicated
        • in remission (early) (sustained) - F14.21 Cocaine dependence, in remission
        • with
          • amphetamine, cocaine, or other stimulant intoxication
            • with perceptual disturbances - F14.222 Cocaine dependence with intoxication with perceptual disturbance
            • without perceptual disturbances - F14.229 Cocaine dependence with intoxication, unspecified
          • cocaine intoxication delirium - F14.221 Cocaine dependence with intoxication delirium
          • cocaine-induced
            • anxiety disorder - F14.280 Cocaine dependence with cocaine-induced anxiety disorder
            • depressive disorder - F14.24 Cocaine dependence with cocaine-induced mood disorder
            • psychotic disorder - F14.259 Cocaine dependence with cocaine-induced psychotic disorder, unspecified
            • sexual dysfunction - F14.281 Cocaine dependence with cocaine-induced sexual dysfunction
            • sleep disorder - F14.282 Cocaine dependence with cocaine-induced sleep disorder
    • coccyx NEC - M53.3 Sacrococcygeal disorders, not elsewhere classified
    • cognitive - F09 Unspecified mental disorder due to known physiological condition
      • due to (secondary to) general medical condition - F09 Unspecified mental disorder due to known physiological condition
      • persisting - R41.89 Other symptoms and signs involving cognitive functions and awareness
        • due to
          • alcohol - F10.97 Alcohol use, unspecified with alcohol-induced persisting dementia
            • with dependence - F10.27 Alcohol dependence with alcohol-induced persisting dementia
          • anxiolytics - F13.97 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
            • with dependence - F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
          • hypnotics - F13.97 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
            • with dependence - F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
          • sedatives - F13.97 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
            • with dependence - F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
          • specified substance NEC - F19.97 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
            • with
              • abuse - F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
              • dependence - F19.27 Other psychoactive substance dependence with psychoactive substance-induced persisting dementia
    • communication - F80.9 Developmental disorder of speech and language, unspecified
      • social pragmatic - F80.82 Social pragmatic communication disorder
    • conduct (childhood) - F91.9 Conduct disorder, unspecified
      • adjustment reaction - See: Disorder, adjustment;
      • adolescent onset type - F91.2 Conduct disorder, adolescent-onset type
      • childhood onset type - F91.1 Conduct disorder, childhood-onset type
      • compulsive - F63.9 Impulse disorder, unspecified
      • confined to family context - F91.0 Conduct disorder confined to family context
      • depressive - F91.8 Other conduct disorders
      • group type - F91.2 Conduct disorder, adolescent-onset type
      • hyperkinetic - See: Disorder, attention-deficit hyperactivity;
      • oppositional defiance - F91.3 Oppositional defiant disorder
      • socialized - F91.2 Conduct disorder, adolescent-onset type
      • solitary aggressive type - F91.1 Conduct disorder, childhood-onset type
      • specified NEC - F91.8 Other conduct disorders
      • unsocialized (aggressive) - F91.1 Conduct disorder, childhood-onset type
    • conduction, heart - I45.9 Conduction disorder, unspecified
    • congenital glycosylation (CDG) - E74.8 Other specified disorders of carbohydrate metabolism
    • conjunctiva - H11.9 Unspecified disorder of conjunctiva
      • infection - See: Conjunctivitis;
    • connective tissue, localized - L94.9 Localized connective tissue disorder, unspecified
      • specified NEC - L94.8 Other specified localized connective tissue disorders
    • conversion (functional neurological symptom disorder)
      • with
        • abnormal movement - F44.4 Conversion disorder with motor symptom or deficit
        • anesthesia or sensory loss - F44.6 Conversion disorder with sensory symptom or deficit
        • attacks or seizures - F44.5 Conversion disorder with seizures or convulsions
        • mixed symptoms - F44.7 Conversion disorder with mixed symptom presentation
        • special sensory symptoms - F44.6 Conversion disorder with sensory symptom or deficit
        • speech symptoms - F44.4 Conversion disorder with motor symptom or deficit
        • swallowing symptoms - F44.4 Conversion disorder with motor symptom or deficit
        • weakness or paralysis - F44.4 Conversion disorder with motor symptom or deficit
    • convulsive (secondary) - See: Convulsions;
    • cornea - H18.9 Unspecified disorder of cornea
      • deformity - See: Deformity, cornea;
      • degeneration - See: Degeneration, cornea;
      • deposits - See: Deposit, cornea;
      • due to contact lens - H18.82 Corneal disorder due to contact lens
        • specified as edema - See: Edema, cornea;
      • edema - See: Edema, cornea;
      • keratitis - See: Keratitis;
      • keratoconjunctivitis - See: Keratoconjunctivitis;
      • membrane change - See: Change, corneal membrane;
      • neovascularization - See: Neovascularization, cornea;
      • scar - See: Opacity, cornea;
      • specified type NEC - H18.89 Other specified disorders of cornea
      • ulcer - See: Ulcer, cornea;
    • corpus cavernosum - N48.9 Disorder of penis, unspecified
    • cranial nerve - See: Disorder, nerve, cranial;
    • cyclothymic - F34.0 Cyclothymic disorder
    • defiant oppositional - F91.3 Oppositional defiant disorder
    • delusional (persistent) (systematized) - F22 Delusional disorders
      • induced - F24 Shared psychotic disorder
    • depersonalization - F48.1 Depersonalization-derealization syndrome
    • depressive - F32.9 Major depressive disorder, single episode, unspecified
      • due to known physiological condition
        • with
          • depressive features - F06.31 Mood disorder due to known physiological condition with depressive features
          • major depressive-like episode - F06.32 Mood disorder due to known physiological condition with major depressive-like episode
          • mixed features - F06.34 Mood disorder due to known physiological condition with mixed features
      • major - F32.9 Major depressive disorder, single episode, unspecified
        • in remission (full) - F32.5 Major depressive disorder, single episode, in full remission
          • partial - F32.4 Major depressive disorder, single episode, in partial remission
        • recurrent - F33.9 Major depressive disorder, recurrent, unspecified
          • with psychotic features - F33.3 Major depressive disorder, recurrent, severe with psychotic symptoms
        • single episode - F32.9 Major depressive disorder, single episode, unspecified
          • mild - F32.0 Major depressive disorder, single episode, mild
          • moderate - F32.1 Major depressive disorder, single episode, moderate
          • severe (without psychotic symptoms) - F32.2 Major depressive disorder, single episode, severe without psychotic features
            • with psychotic symptoms - F32.3 Major depressive disorder, single episode, severe with psychotic features
        • with psychotic symptoms - F32.3 Major depressive disorder, single episode, severe with psychotic features
      • organic - F06.31 Mood disorder due to known physiological condition with depressive features
      • persistent - F34.1 Dysthymic disorder
      • recurrent - F33.9 Major depressive disorder, recurrent, unspecified
        • current episode
          • mild - F33.0 Major depressive disorder, recurrent, mild
          • moderate - F33.1 Major depressive disorder, recurrent, moderate
          • severe (without psychotic symptoms) - F33.2 Major depressive disorder, recurrent severe without psychotic features
            • with psychotic symptoms - F33.3 Major depressive disorder, recurrent, severe with psychotic symptoms
        • in remission - F33.40 Major depressive disorder, recurrent, in remission, unspecified
          • full - F33.42 Major depressive disorder, recurrent, in full remission
          • partial - F33.41 Major depressive disorder, recurrent, in partial remission
        • specified NEC - F33.8 Other recurrent depressive disorders
      • single episode - See: Episode, depressive;
      • specified NEC - F32.89 Other specified depressive episodes
    • developmental - F89 Unspecified disorder of psychological development
      • arithmetical skills - F81.2 Mathematics disorder
      • coordination (motor) - F82 Specific developmental disorder of motor function
      • expressive writing - F81.81 Disorder of written expression
      • language - F80.9 Developmental disorder of speech and language, unspecified
        • expressive - F80.1 Expressive language disorder
        • mixed receptive and expressive - F80.2 Mixed receptive-expressive language disorder
        • receptive type - F80.2 Mixed receptive-expressive language disorder
        • specified NEC - F80.89 Other developmental disorders of speech and language
      • learning - F81.9 Developmental disorder of scholastic skills, unspecified
        • arithmetical - F81.2 Mathematics disorder
        • reading - F81.0 Specific reading disorder
      • mixed - F88 Other disorders of psychological development
      • motor coordination or function - F82 Specific developmental disorder of motor function
      • pervasive - F84.9 Pervasive developmental disorder, unspecified
        • specified NEC - F84.8 Other pervasive developmental disorders
      • phonological - F80.0 Phonological disorder
      • reading - F81.0 Specific reading disorder
      • scholastic skills - See Also: Disorder, learning;
        • mixed - F81.89 Other developmental disorders of scholastic skills
      • specified NEC - F88 Other disorders of psychological development
      • speech - F80.9 Developmental disorder of speech and language, unspecified
        • articulation - F80.0 Phonological disorder
        • specified NEC - F80.89 Other developmental disorders of speech and language
      • written expression - F81.81 Disorder of written expression
    • diaphragm - J98.6 Disorders of diaphragm
    • digestive (system) - K92.9 Disease of digestive system, unspecified
      • newborn - P78.9 Perinatal digestive system disorder, unspecified
        • specified NEC - P78.89 Other specified perinatal digestive system disorders
      • postprocedural - See: Complication, gastrointestinal;
      • psychogenic - F45.8 Other somatoform disorders
    • disc (intervertebral) - M51.9 Unspecified thoracic, thoracolumbar and lumbosacral intervertebral disc disorder
      • cervical - M50.90 Cervical disc disorder, unspecified, unspecified cervical region
        • C2-C3 - M50.91 Cervical disc disorder, unspecified, high cervical region
        • C3-C4 - M50.91 Cervical disc disorder, unspecified, high cervical region
        • C4-C5 - M50.921 Unspecified cervical disc disorder at C4-C5 level
        • C5-C6 - M50.922 Unspecified cervical disc disorder at C5-C6 level
        • C6-C7 - M50.923 Unspecified cervical disc disorder at C6-C7 level
        • C7-T1 - M50.93 Cervical disc disorder, unspecified, cervicothoracic region
        • cervicothoracic region - M50.93 Cervical disc disorder, unspecified, cervicothoracic region
        • degeneration - M50.30 Other cervical disc degeneration, unspecified cervical region
          • C2-C3 - M50.31 Other cervical disc degeneration, high cervical region
          • C3-C4 - M50.31 Other cervical disc degeneration, high cervical region
          • C4-C5 - M50.321 Other cervical disc degeneration at C4-C5 level
          • C5-C6 - M50.322 Other cervical disc degeneration at C5-C6 level
          • C6-C7 - M50.323 Other cervical disc degeneration at C6-C7 level
          • C7-T1 - M50.33 Other cervical disc degeneration, cervicothoracic region
          • cervicothoracic region - M50.33 Other cervical disc degeneration, cervicothoracic region
          • high cervical region - M50.31 Other cervical disc degeneration, high cervical region
          • mid-cervical region - M50.320 Other cervical disc degeneration, mid-cervical region, unspecified level
        • displacement - M50.20 Other cervical disc displacement, unspecified cervical region
          • C2-C3 - M50.21 Other cervical disc displacement, high cervical region
          • C3-C4 - M50.21 Other cervical disc displacement, high cervical region
          • C4-C5 - M50.221 Other cervical disc displacement at C4-C5 level
          • C5-C6 - M50.222 Other cervical disc displacement at C5-C6 level
          • C6-C7 - M50.223 Other cervical disc displacement at C6-C7 level
          • C7-T1 - M50.23 Other cervical disc displacement, cervicothoracic region
          • cervicothoracic region - M50.23 Other cervical disc displacement, cervicothoracic region
          • high cervical region - M50.21 Other cervical disc displacement, high cervical region
          • mid-cervical region - M50.220 Other cervical disc displacement, mid-cervical region, unspecified level
        • high cervical region - M50.91 Cervical disc disorder, unspecified, high cervical region
        • mid-cervical region - M50.920 Unspecified cervical disc disorder, mid-cervical region, unspecified level
        • specified type NEC - M50.80 Other cervical disc disorders, unspecified cervical region
          • C2-C3 - M50.81 Other cervical disc disorders, high cervical region
          • C3-C4 - M50.81 Other cervical disc disorders, high cervical region
          • C4-C5 - M50.821 Other cervical disc disorders at C4-C5 level
          • C5-C6 - M50.822 Other cervical disc disorders at C5-C6 level
          • C6-C7 - M50.823 Other cervical disc disorders at C6-C7 level
          • C7-T1 - M50.83 Other cervical disc disorders, cervicothoracic region
          • cervicothoracic region - M50.83 Other cervical disc disorders, cervicothoracic region
          • high cervical region - M50.81 Other cervical disc disorders, high cervical region
          • mid-cervical region - M50.820 Other cervical disc disorders, mid-cervical region, unspecified level
        • with
          • myelopathy - M50.00 Cervical disc disorder with myelopathy, unspecified cervical region
            • C2-C3 - M50.01 Cervical disc disorder with myelopathy, high cervical region
            • C3-C4 - M50.01 Cervical disc disorder with myelopathy, high cervical region
            • C4-C5 - M50.021 Cervical disc disorder at C4-C5 level with myelopathy
            • C5-C6 - M50.022 Cervical disc disorder at C5-C6 level with myelopathy
            • C6-C7 - M50.023 Cervical disc disorder at C6-C7 level with myelopathy
            • C7-T1 - M50.03 Cervical disc disorder with myelopathy, cervicothoracic region
            • cervicothoracic region - M50.03 Cervical disc disorder with myelopathy, cervicothoracic region
            • high cervical region - M50.01 Cervical disc disorder with myelopathy, high cervical region
            • mid-cervical region - M50.020 Cervical disc disorder with myelopathy, mid-cervical region, unspecified level
          • neuritis, radiculitis or radiculopathy - M50.10 Cervical disc disorder with radiculopathy, unspecified cervical region
            • C2-C3 - M50.11 Cervical disc disorder with radiculopathy, high cervical region
            • C3-C4 - M50.11 Cervical disc disorder with radiculopathy, high cervical region
            • C4-C5 - M50.121 Cervical disc disorder at C4-C5 level with radiculopathy
            • C5-C6 - M50.122 Cervical disc disorder at C5-C6 level with radiculopathy
            • C6-C7 - M50.123 Cervical disc disorder at C6-C7 level with radiculopathy
            • C7-T1 - M50.13 Cervical disc disorder with radiculopathy, cervicothoracic region
            • cervicothoracic region - M50.13 Cervical disc disorder with radiculopathy, cervicothoracic region
            • high cervical region - M50.11 Cervical disc disorder with radiculopathy, high cervical region
            • mid-cervical region - M50.120 Mid-cervical disc disorder, unspecified level
      • specified NEC
        • lumbar region - M51.86 Other intervertebral disc disorders, lumbar region
        • lumbosacral region - M51.87 Other intervertebral disc disorders, lumbosacral region
        • sacrococcygeal region - M53.3 Sacrococcygeal disorders, not elsewhere classified
        • thoracic region - M51.84 Other intervertebral disc disorders, thoracic region
        • thoracolumbar region - M51.85 Other intervertebral disc disorders, thoracolumbar region
      • with
        • myelopathy
          • cervical region - M50.00 Cervical disc disorder with myelopathy, unspecified cervical region
          • cervicothoracic region - M50.03 Cervical disc disorder with myelopathy, cervicothoracic region
          • high cervical region - M50.01 Cervical disc disorder with myelopathy, high cervical region
          • lumbar region - M51.06 Intervertebral disc disorders with myelopathy, lumbar region
          • mid-cervical region - M50.020 Cervical disc disorder with myelopathy, mid-cervical region, unspecified level
          • sacrococcygeal region - M53.3 Sacrococcygeal disorders, not elsewhere classified
          • thoracic region - M51.04 Intervertebral disc disorders with myelopathy, thoracic region
          • thoracolumbar region - M51.05 Intervertebral disc disorders with myelopathy, thoracolumbar region
        • radiculopathy
          • cervical region - M50.10 Cervical disc disorder with radiculopathy, unspecified cervical region
          • cervicothoracic region - M50.13 Cervical disc disorder with radiculopathy, cervicothoracic region
          • high cervical region - M50.11 Cervical disc disorder with radiculopathy, high cervical region
          • lumbar region - M51.16 Intervertebral disc disorders with radiculopathy, lumbar region
          • lumbosacral region - M51.17 Intervertebral disc disorders with radiculopathy, lumbosacral region
          • mid-cervical region - M50.120 Mid-cervical disc disorder, unspecified level
          • sacrococcygeal region - M53.3 Sacrococcygeal disorders, not elsewhere classified
          • thoracic region - M51.14 Intervertebral disc disorders with radiculopathy, thoracic region
          • thoracolumbar region - M51.15 Intervertebral disc disorders with radiculopathy, thoracolumbar region
    • disinhibited attachment (childhood) - F94.2 Disinhibited attachment disorder of childhood
    • disintegrative, childhood NEC - F84.3 Other childhood disintegrative disorder
    • disruptive - F91.9 Conduct disorder, unspecified
      • mood dysregulation - F34.81 Disruptive mood dysregulation disorder
      • specified NEC - F91.8 Other conduct disorders
    • disruptive behavior - See: Disorder, conduct;
    • dissocial personality - F60.2 Antisocial personality disorder
    • dissociative - F44.9 Dissociative and conversion disorder, unspecified
      • affecting
        • motor function - F44.4 Conversion disorder with motor symptom or deficit
          • and sensation - F44.7 Conversion disorder with mixed symptom presentation
        • sensation - F44.6 Conversion disorder with sensory symptom or deficit
          • and motor function - F44.7 Conversion disorder with mixed symptom presentation
      • brief reactive - F43.0 Acute stress reaction
      • due to (secondary to) general medical condition - F06.8 Other specified mental disorders due to known physiological condition
      • mixed - F44.7 Conversion disorder with mixed symptom presentation
      • organic - F06.8 Other specified mental disorders due to known physiological condition
      • other specified NEC - F44.89 Other dissociative and conversion disorders
    • double heterozygous sickling - See: Disease, sickle-cell;
    • dream anxiety - F51.5 Nightmare disorder
    • drug induced hemorrhagic - D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
    • dysmorphic body - F45.22 Body dysmorphic disorder
    • dysthymic - F34.1 Dysthymic disorder
    • ear - H93.9 Unspecified disorder of ear
      • bleeding - See: Otorrhagia;
      • deafness - See: Deafness;
      • degenerative - H93.09 Unspecified degenerative and vascular disorders of ear
      • discharge - See: Otorrhea;
      • external - H61.9 Disorder of external ear, unspecified
        • auditory canal stenosis - See: Stenosis, external ear canal;
        • exostosis - See: Exostosis, external ear canal;
        • impacted cerumen - See: Impaction, cerumen;
        • otitis - See: Otitis, externa;
        • perichondritis - See: Perichondritis, ear;
        • pinna - See: Disorder, pinna;
        • specified type NEC - H61.89 Other specified disorders of external ear
          • in diseases classified elsewhere - H62.8X Other disorders of external ear in diseases classified elsewhere
      • inner - H83.9 Unspecified disease of inner ear
        • vestibular dysfunction - See: Disorder, vestibular function;
      • middle - H74.9 Unspecified disorder of middle ear and mastoid
        • adhesive - H74.1 Adhesive middle ear disease
        • ossicle - See: Abnormal, ear ossicles;
        • polyp - See: Polyp, ear (middle);
        • specified NEC, in diseases classified elsewhere - H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere
      • postprocedural - See: Complications, ear, procedure;
      • specified NEC, in diseases classified elsewhere - H94.8 Other specified disorders of ear in diseases classified elsewhere
    • eating (adult) (psychogenic) - F50.9 Eating disorder, unspecified
      • anorexia - See: Anorexia;
      • binge - F50.81 Binge eating disorder
      • bulimia - F50.2 Bulimia nervosa
      • child - F98.29 Other feeding disorders of infancy and early childhood
        • pica - F98.3 Pica of infancy and childhood
        • rumination disorder - F98.21 Rumination disorder of infancy
      • pica - F50.89 Other specified eating disorder
        • childhood - F98.3 Pica of infancy and childhood
    • electrolyte (balance) NEC - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
      • acidosis (metabolic) (respiratory) - E87.2 Acidosis
      • alkalosis (metabolic) (respiratory) - E87.3 Alkalosis
      • with
        • abortion - See: Abortion by type complicated by specified condition NEC;
        • ectopic pregnancy - O08.5 Metabolic disorders following an ectopic and molar pregnancy
        • molar pregnancy - O08.5 Metabolic disorders following an ectopic and molar pregnancy
    • elimination, transepidermal - L87.9 Transepidermal elimination disorder, unspecified
      • specified NEC - L87.8 Other transepidermal elimination disorders
    • emotional (persistent) - F34.9 Persistent mood [affective] disorder, unspecified
      • of childhood - F93.9 Childhood emotional disorder, unspecified
        • specified NEC - F93.8 Other childhood emotional disorders
    • endocrine - E34.9 Endocrine disorder, unspecified
      • postprocedural - E89.89 Other postprocedural endocrine and metabolic complications and disorders
        • specified NEC - E89.89 Other postprocedural endocrine and metabolic complications and disorders
    • erectile (male) (organic) - See Also: Dysfunction, sexual, male, erectile; - N52.9 Male erectile dysfunction, unspecified
      • nonorganic - F52.21 Male erectile disorder
    • erythematous - See: Erythema;
    • esophagus - K22.9 Disease of esophagus, unspecified
      • functional - K22.4 Dyskinesia of esophagus
      • psychogenic - F45.8 Other somatoform disorders
    • eustachian tube - H69.9 Unspecified Eustachian tube disorder
      • infection - See: Salpingitis, eustachian;
      • obstruction - See: Obstruction, eustachian tube;
      • patulous - See: Patulous, eustachian tube;
      • specified NEC - H69.8 Other specified disorders of Eustachian tube
    • exhibitionistic - F65.2 Exhibitionism
    • extrapyramidal - G25.9 Extrapyramidal and movement disorder, unspecified
      • in diseases classified elsewhere
      • specified type NEC - G25.89 Other specified extrapyramidal and movement disorders
    • eye - H57.9 Unspecified disorder of eye and adnexa
      • postprocedural - See: Complication, postprocedural, eye;
    • eyelid - H02.9 Unspecified disorder of eyelid
      • cyst - See: Cyst, eyelid;
      • degenerative - H02.70 Unspecified degenerative disorders of eyelid and periocular area
        • chloasma - See: Chloasma, eyelid;
        • madarosis - See: Madarosis;
        • specified type NEC - H02.79 Other degenerative disorders of eyelid and periocular area
        • vitiligo - See: Vitiligo, eyelid;
        • xanthelasma - See: Xanthelasma;
      • dermatochalasis - See: Dermatochalasis;
      • edema - See: Edema, eyelid;
      • elephantiasis - See: Elephantiasis, eyelid;
      • foreign body, retained - See: Foreign body, retained, eyelid;
      • function - H02.59 Other disorders affecting eyelid function
        • abnormal innervation syndrome - See: Syndrome, abnormal innervation;
        • blepharochalasis - See: Blepharochalasis;
        • blepharoclonus - See: Blepharoclonus;
        • blepharophimosis - See: Blepharophimosis;
        • blepharoptosis - See: Blepharoptosis;
        • lagophthalmos - See: Lagophthalmos;
        • lid retraction - See: Retraction, lid;
      • hypertrichosis - See: Hypertrichosis, eyelid;
      • specified type NEC - H02.89 Other specified disorders of eyelid
      • vascular - H02.879 Vascular anomalies of unspecified eye, unspecified eyelid
        • left - H02.876 Vascular anomalies of left eye, unspecified eyelid
          • lower - H02.875 Vascular anomalies of left lower eyelid
          • upper - H02.874 Vascular anomalies of left upper eyelid
        • right - H02.873 Vascular anomalies of right eye, unspecified eyelid
          • lower - H02.872 Vascular anomalies of right lower eyelid
          • upper - H02.871 Vascular anomalies of right upper eyelid
    • factitious
      • by proxy - F68.A Factitious disorder imposed on another
      • imposed on another - F68.A Factitious disorder imposed on another
      • imposed on self - F68.10 Factitious disorder imposed on self, unspecified
        • with predominantly
          • physical symptoms - F68.12 Factitious disorder imposed on self, with predominantly physical signs and symptoms
            • with psychological symptoms - F68.13 Factitious disorder imposed on self, with combined psychological and physical signs and symptoms
          • psychological symptoms - F68.11 Factitious disorder imposed on self, with predominantly psychological signs and symptoms
            • with physical symptoms - F68.13 Factitious disorder imposed on self, with combined psychological and physical signs and symptoms
    • factor, coagulation - See: Defect, coagulation;
    • fatty acid
      • metabolism - E71.30 Disorder of fatty-acid metabolism, unspecified
        • specified NEC - E71.39 Other disorders of fatty-acid metabolism
      • oxidation
        • LCAD - E71.310 Long chain/very long chain acyl CoA dehydrogenase deficiency
        • MCAD - E71.311 Medium chain acyl CoA dehydrogenase deficiency
        • SCAD - E71.312 Short chain acyl CoA dehydrogenase deficiency
        • specified deficiency NEC - E71.318 Other disorders of fatty-acid oxidation
    • feeding (infant or child) - See Also: Disorder, eating; - R63.3 Feeding difficulties
      • or eating disorder - F50.9 Eating disorder, unspecified
      • specified NEC - F50.9 Eating disorder, unspecified
    • feigned (with obvious motivation) - Z76.5 Malingerer [conscious simulation]
      • without obvious motivation - See: Disorder, factitious;
    • female
      • hypoactive sexual desire - F52.0 Hypoactive sexual desire disorder
      • orgasmic - F52.31 Female orgasmic disorder
      • sexual interest/arousal - F52.22 Female sexual arousal disorder
    • fetishistic - F65.0 Fetishism
    • fibroblastic - M72.9 Fibroblastic disorder, unspecified
      • specified NEC - M72.8 Other fibroblastic disorders
    • fluency
      • adult onset - F98.5 Adult onset fluency disorder
      • childhood onset - F80.81 Childhood onset fluency disorder
      • following
        • cerebral infarction - I69.323 Fluency disorder following cerebral infarction
        • cerebrovascular disease - I69.923 Fluency disorder following unspecified cerebrovascular disease
          • specified disease NEC - I69.823 Fluency disorder following other cerebrovascular disease
        • intracerebral hemorrhage - I69.123 Fluency disorder following nontraumatic intracerebral hemorrhage
        • nontraumatic intracranial hemorrhage NEC - I69.223 Fluency disorder following other nontraumatic intracranial hemorrhage
        • subarachnoid hemorrhage - I69.023 Fluency disorder following nontraumatic subarachnoid hemorrhage
      • in conditions classified elsewhere - R47.82 Fluency disorder in conditions classified elsewhere
    • fluid balance - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
    • follicular (skin) - L73.9 Follicular disorder, unspecified
      • specified NEC - L73.8 Other specified follicular disorders
    • frotteuristic - F65.81 Frotteurism
    • fructose metabolism - E74.10 Disorder of fructose metabolism, unspecified
      • essential fructosuria - E74.11 Essential fructosuria
      • fructokinase deficiency - E74.11 Essential fructosuria
      • fructose-1, 6-diphosphatase deficiency - E74.19 Other disorders of fructose metabolism
      • hereditary fructose intolerance - E74.12 Hereditary fructose intolerance
      • other specified - E74.19 Other disorders of fructose metabolism
    • functional polymorphonuclear neutrophils - D71 Functional disorders of polymorphonuclear neutrophils
    • gallbladder, biliary tract and pancreas in diseases classified elsewhere - K87 Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere
    • gambling - F63.0 Pathological gambling
    • gamma aminobutyric acid (GABA) metabolism - E72.81 Disorders of gamma aminobutyric acid metabolism
    • gamma-glutamyl cycle - E72.89 Other specified disorders of amino-acid metabolism
    • gastric (functional) - K31.9 Disease of stomach and duodenum, unspecified
      • motility - K30 Functional dyspepsia
      • psychogenic - F45.8 Other somatoform disorders
      • secretion - K30 Functional dyspepsia
    • gastrointestinal (functional) NOS - K92.9 Disease of digestive system, unspecified
      • newborn - P78.9 Perinatal digestive system disorder, unspecified
      • psychogenic - F45.8 Other somatoform disorders
    • gender-identity or -role - F64.9 Gender identity disorder, unspecified
      • childhood - F64.2 Gender identity disorder of childhood
      • effect on relationship - F66 Other sexual disorders
      • of adolescence or adulthood - F64.0 Transsexualism
        • nontranssexual - F64.8 Other gender identity disorders
      • specified NEC - F64.8 Other gender identity disorders
      • uncertainty - F66 Other sexual disorders
    • genito-pelvic pain penetration - F52.6 Dyspareunia not due to a substance or known physiological condition
    • genitourinary system
      • female - N94.9 Unspecified condition associated with female genital organs and menstrual cycle
      • male - N50.9 Disorder of male genital organs, unspecified
      • psychogenic - F45.8 Other somatoform disorders
    • globe - H44.9 Unspecified disorder of globe
      • degenerated condition - H44.50 Unspecified degenerated conditions of globe
        • absolute glaucoma - H44.51 Absolute glaucoma
        • atrophy - H44.52 Atrophy of globe
        • leucocoria - H44.53 Leucocoria
      • degenerative - H44.30 Unspecified degenerative disorder of globe
        • chalcosis - H44.31 Chalcosis
        • myopia - See Also: Myopia, degenerative; - H44.2 Degenerative myopia
        • siderosis - H44.32 Siderosis of eye
        • specified type NEC - H44.39 Other degenerative disorders of globe
      • endophthalmitis - See: Endophthalmitis;
      • foreign body, retained - See: Foreign body, intraocular, old, retained;
      • hemophthalmos - See: Hemophthalmos;
      • hypotony - H44.40 Unspecified hypotony of eye
        • due to
          • ocular fistula - H44.42 Hypotony of eye due to ocular fistula
          • specified disorder NEC - H44.43 Hypotony of eye due to other ocular disorders
        • flat anterior chamber - H44.41 Flat anterior chamber hypotony of eye
        • primary - H44.44 Primary hypotony of eye
      • luxation - See: Luxation, globe;
      • specified type NEC - H44.89 Other disorders of globe
    • glomerular (in) - N05.9 Unspecified nephritic syndrome with unspecified morphologic changes
      • amyloidosis - E85.4 Organ-limited amyloidosis
      • cryoglobulinemia - D89.1 Cryoglobulinemia
      • disseminated intravascular coagulation - D65 Disseminated intravascular coagulation [defibrination syndrome]
      • Fabry's disease - E75.21 Fabry (-Anderson) disease
      • familial lecithin cholesterol acyltransferase deficiency - E78.6 Lipoprotein deficiency
      • Goodpasture's syndrome - M31.0 Hypersensitivity angiitis
      • hemolytic-uremic syndrome - D59.3 Hemolytic-uremic syndrome
      • Henoch (-Schönlein) purpura - D69.0 Allergic purpura
      • malariae malaria - B52.0 Plasmodium malariae malaria with nephropathy
      • microscopic polyangiitis - M31.7 Microscopic polyangiitis
      • multiple myeloma - C90.0 Multiple myeloma
      • mumps - B26.83 Mumps nephritis
      • schistosomiasis - B65.9 Schistosomiasis, unspecified
      • sepsis NEC - A41.
        • streptococcal - A40.
      • sickle-cell disorders - D57.
      • strongyloidiasis - B78.9 Strongyloidiasis, unspecified
      • subacute bacterial endocarditis - I33.0 Acute and subacute infective endocarditis
      • syphilis - A52.75 Syphilis of kidney and ureter
      • systemic lupus erythematosus - M32.14 Glomerular disease in systemic lupus erythematosus
      • thrombotic thrombocytopenic purpura - M31.1 Thrombotic microangiopathy
      • Waldenström macroglobulinemia - C88.0 Waldenstrom macroglobulinemia
      • Wegener's granulomatosis - M31.31 Wegener's granulomatosis with renal involvement
    • gluconeogenesis - E74.4 Disorders of pyruvate metabolism and gluconeogenesis
    • glucosaminoglycan metabolism - See: Disorder, metabolism, glucosaminoglycan;
    • glycine metabolism - E72.50 Disorder of glycine metabolism, unspecified
      • d-glycericacidemia - E72.59 Other disorders of glycine metabolism
      • hyperhydroxyprolinemia - E72.59 Other disorders of glycine metabolism
      • hyperoxaluria - R82.992 Hyperoxaluria
        • primary - E72.53 Primary hyperoxaluria
      • hyperprolinemia - E72.59 Other disorders of glycine metabolism
      • non-ketotic hyperglycinemia - E72.51 Non-ketotic hyperglycinemia
      • oxalosis - E72.53 Primary hyperoxaluria
      • oxaluria - E72.53 Primary hyperoxaluria
      • sarcosinemia - E72.59 Other disorders of glycine metabolism
      • trimethylaminuria - E72.52 Trimethylaminuria
    • glycoprotein metabolism - E77.9 Disorder of glycoprotein metabolism, unspecified
      • specified NEC - E77.8 Other disorders of glycoprotein metabolism
    • habit (and impulse) - F63.9 Impulse disorder, unspecified
      • involving sexual behavior NEC - F65.9 Paraphilia, unspecified
      • specified NEC - F63.89 Other impulse disorders
    • hallucinogen use
      • mild - F16.10 Hallucinogen abuse, uncomplicated
        • in remission (early) (sustained) - F16.11 Hallucinogen abuse, in remission
        • with
          • hallucinogen intoxication delirium - F16.121 Hallucinogen abuse with intoxication with delirium
          • hallucinogen-induced
            • anxiety disorder - F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
            • depressive disorder - F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
            • psychotic disorder - F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
          • other hallucinogen intoxication - F16.129 Hallucinogen abuse with intoxication, unspecified
      • moderate or severe - F16.20 Hallucinogen dependence, uncomplicated
        • in remission (early) (sustained) - F16.21 Hallucinogen dependence, in remission
        • with
          • hallucinogen intoxication delirium - F16.221 Hallucinogen dependence with intoxication with delirium
          • hallucinogen-induced
            • anxiety disorder - F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
            • depressive disorder - F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder
            • psychotic disorder - F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
          • other hallucinogen intoxication - F16.229 Hallucinogen dependence with intoxication, unspecified
    • heart action - I49.9 Cardiac arrhythmia, unspecified
    • hematological - D75.9 Disease of blood and blood-forming organs, unspecified
      • newborn (transient) - P61.9 Perinatal hematological disorder, unspecified
        • specified NEC - P61.8 Other specified perinatal hematological disorders
    • hematopoietic organs - D75.9 Disease of blood and blood-forming organs, unspecified
    • hemorrhagic NEC - D69.9 Hemorrhagic condition, unspecified
      • drug-induced - D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
      • due to
        • extrinsic circulating anticoagulants - D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
        • increase in
          • anti-IIa - D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
          • anti-Xa - D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
        • intrinsic
          • circulating anticoagulants - D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
          • increase in
            • anti-IXa - D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
            • antithrombin - D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
            • anti-VIIIa - D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
            • anti-XIa - D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
      • following childbirth - O72.3 Postpartum coagulation defects
    • hemostasis - See: Defect, coagulation;
    • histidine metabolism - E70.40 Disorders of histidine metabolism, unspecified
      • histidinemia - E70.41 Histidinemia
      • other specified - E70.49 Other disorders of histidine metabolism
    • hoarding - F42.3 Hoarding disorder
    • hyperkinetic - See: Disorder, attention-deficit hyperactivity;
    • hyperleucine-isoleucinemia - E71.19 Other disorders of branched-chain amino-acid metabolism
    • hypervalinemia - E71.19 Other disorders of branched-chain amino-acid metabolism
    • hypoactive sexual desire - F52.0 Hypoactive sexual desire disorder
    • hypochondriacal - F45.20 Hypochondriacal disorder, unspecified
      • body dysmorphic - F45.22 Body dysmorphic disorder
      • neurosis - F45.21 Hypochondriasis
      • other specified - F45.29 Other hypochondriacal disorders
    • identity
      • dissociative - F44.81 Dissociative identity disorder
      • illness anxiety - F45.21 Hypochondriasis
      • of childhood - F93.8 Other childhood emotional disorders
    • immune mechanism (immunity) - D89.9 Disorder involving the immune mechanism, unspecified
      • specified type NEC - D89.89 Other specified disorders involving the immune mechanism, not elsewhere classified
    • impaired renal tubular function - N25.9 Disorder resulting from impaired renal tubular function, unspecified
      • specified NEC - N25.89 Other disorders resulting from impaired renal tubular function
    • impulse (control) - F63.9 Impulse disorder, unspecified
    • inflammatory
      • pelvic, in diseases classified elsewhere
      • penis - N48.29 Other inflammatory disorders of penis
        • abscess - N48.21 Abscess of corpus cavernosum and penis
        • cellulitis - N48.22 Cellulitis of corpus cavernosum and penis
    • inhalant use
      • mild - F18.10 Inhalant abuse, uncomplicated
        • in remission (early) (sustained) - F18.11 Inhalant abuse, in remission
        • with
          • inhalant intoxication - F18.129 Inhalant abuse with intoxication, unspecified
          • inhalant intoxication delirium - F18.121 Inhalant abuse with intoxication delirium
          • inhalant-induced
            • anxiety disorder - F18.180 Inhalant abuse with inhalant-induced anxiety disorder
            • depressive disorder - F18.14 Inhalant abuse with inhalant-induced mood disorder
            • major neurocognitive disorder - F18.17 Inhalant abuse with inhalant-induced dementia
            • mild neurocognitive disorder - F18.188 Inhalant abuse with other inhalant-induced disorder
            • psychotic disorder - F18.159 Inhalant abuse with inhalant-induced psychotic disorder, unspecified
      • moderate or severe - F18.20 Inhalant dependence, uncomplicated
        • in remission (early) (sustained) - F18.21 Inhalant dependence, in remission
        • with
          • inhalant intoxication - F18.229 Inhalant dependence with intoxication, unspecified
          • inhalant intoxication delirium - F18.221 Inhalant dependence with intoxication delirium
          • inhalant-induced
            • anxiety disorder - F18.280 Inhalant dependence with inhalant-induced anxiety disorder
            • depressive disorder - F18.24 Inhalant dependence with inhalant-induced mood disorder
            • major neurocognitive disorder - F18.27 Inhalant dependence with inhalant-induced dementia
            • mild neurocognitive disorder - F18.288 Inhalant dependence with other inhalant-induced disorder
            • psychotic disorder - F18.259 Inhalant dependence with inhalant-induced psychotic disorder, unspecified
    • integument, newborn - P83.9 Condition of the integument specific to newborn, unspecified
      • specified NEC - P83.88 Other specified conditions of integument specific to newborn
    • intermittent explosive - F63.81 Intermittent explosive disorder
    • internal secretion pancreas - See: Increased, secretion, pancreas, endocrine;
    • intestine, intestinal
      • carbohydrate absorption NEC - E74.39 Other disorders of intestinal carbohydrate absorption
        • postoperative - K91.2 Postsurgical malabsorption, not elsewhere classified
      • functional NEC - K59.9 Functional intestinal disorder, unspecified
        • postoperative - K91.89 Other postprocedural complications and disorders of digestive system
      • psychogenic - F45.8 Other somatoform disorders
      • vascular - K55.9 Vascular disorder of intestine, unspecified
        • chronic - K55.1 Chronic vascular disorders of intestine
        • specified NEC - K55.8 Other vascular disorders of intestine
    • intraoperative (intraprocedural) - See: Complications, intraoperative;
    • involuntary emotional expression (IEED) - F48.2 Pseudobulbar affect
    • iris - H21.9 Unspecified disorder of iris and ciliary body
      • adhesions - See: Adhesions, iris;
      • atrophy - See: Atrophy, iris;
      • chamber angle recession - See: Recession, chamber angle;
      • cyst - See: Cyst, iris;
      • degeneration - See: Degeneration, iris;
      • in diseases classified elsewhere - H22 Disorders of iris and ciliary body in diseases classified elsewhere
      • iridodialysis - See: Iridodialysis;
      • iridoschisis - See: Iridoschisis;
      • miotic pupillary cyst - See: Cyst, pupillary;
      • pupillary
        • abnormality - See: Abnormality, pupillary;
        • membrane - See: Membrane, pupillary;
      • specified type NEC - H21.89 Other specified disorders of iris and ciliary body
      • vascular NEC - H21.1X Other vascular disorders of iris and ciliary body
    • iron metabolism - E83.10 Disorder of iron metabolism, unspecified
      • specified NEC - E83.19 Other disorders of iron metabolism
    • isovaleric acidemia - E71.110 Isovaleric acidemia
    • jaw, developmental - M27.0 Developmental disorders of jaws
      • temporomandibular - See Also: Anomaly, dentofacial, temporomandibular joint; - M26.60 Temporomandibular joint disorder, unspecified
    • joint - M25.9 Joint disorder, unspecified
      • derangement - See: Derangement, joint;
      • effusion - See: Effusion, joint;
      • fistula - See: Fistula, joint;
      • hemarthrosis - See: Hemarthrosis;
      • instability - See: Instability, joint;
      • osteophyte - See: Osteophyte;
      • pain - See: Pain, joint;
      • psychogenic - F45.8 Other somatoform disorders
      • specified type NEC - M25.80 Other specified joint disorders, unspecified joint
        • ankle - M25.87 Other specified joint disorders, ankle and foot
        • elbow - M25.82 Other specified joint disorders, elbow
        • foot joint - M25.87 Other specified joint disorders, ankle and foot
        • hand joint - M25.84 Other specified joint disorders, hand
        • hip - M25.85 Other specified joint disorders, hip
        • knee - M25.86 Other specified joint disorders, knee
        • shoulder - M25.81 Other specified joint disorders, shoulder
        • wrist - M25.83 Other specified joint disorders, wrist
      • stiffness - See: Stiffness, joint;
    • ketone metabolism - E71.32 Disorders of ketone metabolism
    • kidney - N28.9 Disorder of kidney and ureter, unspecified
      • functional (tubular) - N25.9 Disorder resulting from impaired renal tubular function, unspecified
      • in
        • schistosomiasis - B65.9 Schistosomiasis, unspecified
      • tubular function - N25.9 Disorder resulting from impaired renal tubular function, unspecified
        • specified NEC - N25.89 Other disorders resulting from impaired renal tubular function
    • lacrimal system - H04.9 Disorder of lacrimal system, unspecified
      • changes - H04.69 Other changes of lacrimal passages
        • fistula - See: Fistula, lacrimal;
      • gland - H04.19 Other specified disorders of lacrimal gland
        • atrophy - See: Atrophy, lacrimal gland;
        • cyst - See: Cyst, lacrimal, gland;
        • dacryops - See: Dacryops;
        • dislocation - See: Dislocation, lacrimal gland;
        • dry eye syndrome - See: Syndrome, dry eye;
        • infection - See: Dacryoadenitis;
      • granuloma - See: Granuloma, lacrimal;
      • inflammation - See: Inflammation, lacrimal;
      • obstruction - See: Obstruction, lacrimal;
      • specified NEC - H04.89 Other disorders of lacrimal system
    • lactation NEC - O92.79 Other disorders of lactation
    • language (developmental) - F80.9 Developmental disorder of speech and language, unspecified
      • expressive - F80.1 Expressive language disorder
      • mixed receptive and expressive - F80.2 Mixed receptive-expressive language disorder
      • receptive - F80.2 Mixed receptive-expressive language disorder
    • late luteal phase dysphoric - N94.89 Other specified conditions associated with female genital organs and menstrual cycle
    • learning (specific) - F81.9 Developmental disorder of scholastic skills, unspecified
      • acalculia - R48.8 Other symbolic dysfunctions
      • alexia - R48.0 Dyslexia and alexia
      • mathematics - F81.2 Mathematics disorder
      • reading - F81.0 Specific reading disorder
      • specified
        • with impairment in
          • mathematics - F81.2 Mathematics disorder
          • reading - F81.0 Specific reading disorder
          • written expression - F81.81 Disorder of written expression
      • specified NEC - F81.89 Other developmental disorders of scholastic skills
      • spelling - F81.81 Disorder of written expression
      • written expression - F81.81 Disorder of written expression
    • lens - H27.9 Unspecified disorder of lens
      • aphakia - See: Aphakia;
      • cataract - See: Cataract;
      • dislocation - See: Dislocation, lens;
      • specified type NEC - H27.8 Other specified disorders of lens
    • ligament - M24.20 Disorder of ligament, unspecified site
      • ankle - M24.27 Disorder of ligament, ankle and foot
      • attachment, spine - See: Enthesopathy, spinal;
      • elbow - M24.22 Disorder of ligament, elbow
      • foot joint - M24.27 Disorder of ligament, ankle and foot
      • hand joint - M24.24 Disorder of ligament, hand
      • hip - M24.25 Disorder of ligament, hip
      • knee - See: Derangement, knee, specified NEC;
      • shoulder - M24.21 Disorder of ligament, shoulder
      • vertebra - M24.28 Disorder of ligament, vertebrae
      • wrist - M24.23 Disorder of ligament, wrist
    • ligamentous attachments - See Also: Enthesopathy;
      • spine - See: Enthesopathy, spinal;
    • lipid
      • metabolism, congenital - E78.9 Disorder of lipoprotein metabolism, unspecified
      • storage - E75.6 Lipid storage disorder, unspecified
        • specified NEC - E75.5 Other lipid storage disorders
    • lipoprotein
      • deficiency (familial) - E78.6 Lipoprotein deficiency
      • metabolism - E78.9 Disorder of lipoprotein metabolism, unspecified
        • specified NEC - E78.89 Other lipoprotein metabolism disorders
    • liver - K76.9 Liver disease, unspecified
      • malarial - B54 Unspecified malaria
    • low back - See Also: Dorsopathy, specified NEC;
    • lumbosacral
      • plexus - G54.1 Lumbosacral plexus disorders
      • root (nerve) NEC - G54.4 Lumbosacral root disorders, not elsewhere classified
    • lung, interstitial, drug-induced - J70.4 Drug-induced interstitial lung disorders, unspecified
      • acute - J70.2 Acute drug-induced interstitial lung disorders
      • chronic - J70.3 Chronic drug-induced interstitial lung disorders
    • lymphoproliferative, post-transplant (PTLD) - D47.Z1 Post-transplant lymphoproliferative disorder (PTLD)
    • lysine and hydroxylysine metabolism - E72.3 Disorders of lysine and hydroxylysine metabolism
    • major neurocognitive - See: Dementia, in (due to);
    • male
      • erectile (organic) - See Also: Dysfunction, sexual, male, erectile; - N52.9 Male erectile dysfunction, unspecified
        • nonorganic - F52.21 Male erectile disorder
      • hypoactive sexual desire - F52.0 Hypoactive sexual desire disorder
      • orgasmic - F52.32 Male orgasmic disorder
    • manic - F30.9 Manic episode, unspecified
      • organic - F06.33 Mood disorder due to known physiological condition with manic features
    • mast cell activation - See: Activation, mast cell;
    • mastoid - See Also: Disorder, ear, middle;
      • postprocedural - See: Complications, ear, procedure;
    • meniscus - See: Derangement, knee, meniscus;
    • menopausal - N95.9 Unspecified menopausal and perimenopausal disorder
      • specified NEC - N95.8 Other specified menopausal and perimenopausal disorders
    • menstrual - N92.6 Irregular menstruation, unspecified
      • psychogenic - F45.8 Other somatoform disorders
      • specified NEC - N92.5 Other specified irregular menstruation
    • mental (or behavioral) (nonpsychotic) - F99 Mental disorder, not otherwise specified
      • due to (secondary to)
        • amphetamine
          • due to drug abuse - See: Abuse, drug, stimulant;
          • due to drug dependence - See: Dependence, drug, stimulant;
        • brain disease, damage and dysfunction - F09 Unspecified mental disorder due to known physiological condition
        • caffeine use
          • due to drug abuse - See: Abuse, drug, stimulant;
          • due to drug dependence - See: Dependence, drug, stimulant;
        • cannabis use
          • due to drug abuse - See: Abuse, drug, cannabis;
          • due to drug dependence - See: Dependence, drug, cannabis;
        • general medical condition - F09 Unspecified mental disorder due to known physiological condition
        • sedative or hypnotic use
          • due to drug abuse - See: Abuse, drug, sedative;
          • due to drug dependence - See: Dependence, drug, sedative;
        • tobacco (nicotine) use - See: Dependence, drug, nicotine;
      • following organic brain damage - F07.9 Unspecified personality and behavioral disorder due to known physiological condition
        • frontal lobe syndrome - F07.0 Personality change due to known physiological condition
        • personality change - F07.0 Personality change due to known physiological condition
        • postconcussional syndrome - F07.81 Postconcussional syndrome
        • specified NEC - F07.89 Other personality and behavioral disorders due to known physiological condition
      • infancy, childhood or adolescence - F98.9 Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence
      • neurotic - See: Neurosis;
      • organic or symptomatic - F09 Unspecified mental disorder due to known physiological condition
      • presenile, psychotic - F03 Unspecified dementia
      • problem NEC
      • psychoneurotic - See: Neurosis;
      • psychotic - See: Psychosis;
      • puerperal - F53.0 Postpartum depression
      • senile, psychotic NEC - F03 Unspecified dementia
    • metabolic, amino acid, transitory, newborn - P74.8 Other transitory metabolic disturbances of newborn
    • metabolism NOS - E88.9 Metabolic disorder, unspecified
      • amino-acid - E72.9 Disorder of amino-acid metabolism, unspecified
        • aromatic - E70.9 Disorder of aromatic amino-acid metabolism, unspecified
          • albinism - See: Albinism;
          • histidine - E70.40 Disorders of histidine metabolism, unspecified
            • histidinemia - E70.41 Histidinemia
            • other specified - E70.49 Other disorders of histidine metabolism
          • hyperphenylalaninemia - E70.1 Other hyperphenylalaninemias
            • classical phenylketonuria - E70.0 Classical phenylketonuria
          • other specified - E70.8 Other disorders of aromatic amino-acid metabolism
          • tryptophan - E70.5 Disorders of tryptophan metabolism
          • tyrosine - E70.20 Disorder of tyrosine metabolism, unspecified
            • hypertyrosinemia - E70.21 Tyrosinemia
            • other specified - E70.29 Other disorders of tyrosine metabolism
        • branched chain - E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
          • 3-methylglutaconic aciduria - E71.111 3-methylglutaconic aciduria
          • hyperleucine-isoleucinemia - E71.19 Other disorders of branched-chain amino-acid metabolism
          • hypervalinemia - E71.19 Other disorders of branched-chain amino-acid metabolism
          • isovaleric acidemia - E71.110 Isovaleric acidemia
          • maple syrup urine disease - E71.0 Maple-syrup-urine disease
          • methylmalonic acidemia - E71.120 Methylmalonic acidemia
          • organic aciduria NEC - E71.118 Other branched-chain organic acidurias
          • other specified - E71.19 Other disorders of branched-chain amino-acid metabolism
          • proprionate NEC - E71.128 Other disorders of propionate metabolism
          • proprionic acidemia - E71.121 Propionic acidemia
        • glycine - E72.50 Disorder of glycine metabolism, unspecified
          • d-glycericacidemia - E72.59 Other disorders of glycine metabolism
          • hyperhydroxyprolinemia - E72.59 Other disorders of glycine metabolism
          • hyperoxaluria - R82.992 Hyperoxaluria
            • primary - E72.53 Primary hyperoxaluria
          • hyperprolinemia - E72.59 Other disorders of glycine metabolism
          • non-ketotic hyperglycinemia - E72.51 Non-ketotic hyperglycinemia
          • other specified - E72.59 Other disorders of glycine metabolism
          • sarcosinemia - E72.59 Other disorders of glycine metabolism
          • trimethylaminuria - E72.52 Trimethylaminuria
        • hydroxylysine - E72.3 Disorders of lysine and hydroxylysine metabolism
        • lysine - E72.3 Disorders of lysine and hydroxylysine metabolism
        • ornithine - E72.4 Disorders of ornithine metabolism
        • other specified - E72.89 Other specified disorders of amino-acid metabolism
          • beta-amino acid - E72.89 Other specified disorders of amino-acid metabolism
          • gamma-glutamyl cycle - E72.89 Other specified disorders of amino-acid metabolism
        • straight-chain - E72.89 Other specified disorders of amino-acid metabolism
        • sulfur-bearing - E72.10 Disorders of sulfur-bearing amino-acid metabolism, unspecified
          • homocystinuria - E72.11 Homocystinuria
          • methylenetetrahydrofolate reductase deficiency - E72.12 Methylenetetrahydrofolate reductase deficiency
          • other specified - E72.19 Other disorders of sulfur-bearing amino-acid metabolism
      • bile acid and cholesterol metabolism - E78.70 Disorder of bile acid and cholesterol metabolism, unspecified
      • bilirubin - E80.7 Disorder of bilirubin metabolism, unspecified
        • specified NEC - E80.6 Other disorders of bilirubin metabolism
      • calcium - E83.50 Unspecified disorder of calcium metabolism
        • hypercalcemia - E83.52 Hypercalcemia
        • hypocalcemia - E83.51 Hypocalcemia
        • other specified - E83.59 Other disorders of calcium metabolism
      • carbohydrate - E74.9 Disorder of carbohydrate metabolism, unspecified
        • specified NEC - E74.8 Other specified disorders of carbohydrate metabolism
      • cholesterol and bile acid metabolism - E78.70 Disorder of bile acid and cholesterol metabolism, unspecified
      • congenital - E88.9 Metabolic disorder, unspecified
      • copper - E83.00 Disorder of copper metabolism, unspecified
        • specified type NEC - E83.09 Other disorders of copper metabolism
        • Wilson's disease - E83.01 Wilson's disease
      • cystinuria - E72.01 Cystinuria
      • fructose - E74.10 Disorder of fructose metabolism, unspecified
      • galactose - E74.20 Disorders of galactose metabolism, unspecified
      • glucosaminoglycan - E76.9 Glucosaminoglycan metabolism disorder, unspecified
        • mucopolysaccharidosis - See: Mucopolysaccharidosis;
        • specified NEC - E76.8 Other disorders of glucosaminoglycan metabolism
      • glutamine - E72.89 Other specified disorders of amino-acid metabolism
      • glycine - E72.50 Disorder of glycine metabolism, unspecified
      • glycogen storage (hepatorenal) - E74.09 Other glycogen storage disease
      • glycoprotein - E77.9 Disorder of glycoprotein metabolism, unspecified
        • specified NEC - E77.8 Other disorders of glycoprotein metabolism
      • glycosaminoglycan - E76.9 Glucosaminoglycan metabolism disorder, unspecified
        • specified NEC - E76.8 Other disorders of glucosaminoglycan metabolism
      • in labor and delivery - O75.89 Other specified complications of labor and delivery
      • iron - E83.10 Disorder of iron metabolism, unspecified
      • isoleucine - E71.19 Other disorders of branched-chain amino-acid metabolism
      • leucine - E71.19 Other disorders of branched-chain amino-acid metabolism
      • lipoid - E78.9 Disorder of lipoprotein metabolism, unspecified
      • lipoprotein - E78.9 Disorder of lipoprotein metabolism, unspecified
        • specified NEC - E78.89 Other lipoprotein metabolism disorders
      • magnesium - E83.40 Disorders of magnesium metabolism, unspecified
        • hypermagnesemia - E83.41 Hypermagnesemia
        • hypomagnesemia - E83.42 Hypomagnesemia
        • other specified - E83.49 Other disorders of magnesium metabolism
      • mineral - E83.9 Disorder of mineral metabolism, unspecified
        • specified NEC - E83.89 Other disorders of mineral metabolism
      • mitochondrial - E88.40 Mitochondrial metabolism disorder, unspecified
        • MELAS syndrome - E88.41 MELAS syndrome
        • MERRF syndrome (myoclonic epilepsy associated with ragged-red fibers) - E88.42 MERRF syndrome
        • other specified - E88.49 Other mitochondrial metabolism disorders
      • ornithine - E72.4 Disorders of ornithine metabolism
      • phosphatases - E83.30 Disorder of phosphorus metabolism, unspecified
      • phosphorus - E83.30 Disorder of phosphorus metabolism, unspecified
        • acid phosphatase deficiency - E83.39 Other disorders of phosphorus metabolism
        • hypophosphatasia - E83.39 Other disorders of phosphorus metabolism
        • hypophosphatemia - E83.39 Other disorders of phosphorus metabolism
          • familial - E83.31 Familial hypophosphatemia
        • other specified - E83.39 Other disorders of phosphorus metabolism
        • pseudovitamin D deficiency - E83.32 Hereditary vitamin D-dependent rickets (type 1) (type 2)
      • plasma protein NEC - E88.09 Other disorders of plasma-protein metabolism, not elsewhere classified
      • porphyrin - See: Porphyria;
      • postprocedural - E89.89 Other postprocedural endocrine and metabolic complications and disorders
        • specified NEC - E89.89 Other postprocedural endocrine and metabolic complications and disorders
      • purine - E79.9 Disorder of purine and pyrimidine metabolism, unspecified
        • specified NEC - E79.8 Other disorders of purine and pyrimidine metabolism
      • pyrimidine - E79.9 Disorder of purine and pyrimidine metabolism, unspecified
        • specified NEC - E79.8 Other disorders of purine and pyrimidine metabolism
      • pyruvate - E74.4 Disorders of pyruvate metabolism and gluconeogenesis
      • serine - E72.89 Other specified disorders of amino-acid metabolism
      • sodium - E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
      • specified NEC - E88.89 Other specified metabolic disorders
      • threonine - E72.89 Other specified disorders of amino-acid metabolism
      • valine - E71.19 Other disorders of branched-chain amino-acid metabolism
      • zinc - E83.2 Disorders of zinc metabolism
    • methylmalonic acidemia - E71.120 Methylmalonic acidemia
    • micturition NEC - See Also: Difficulty, micturition; - R39.198 Other difficulties with micturition
      • feeling of incomplete emptying - R39.14 Feeling of incomplete bladder emptying
      • hesitancy - R39.11 Hesitancy of micturition
      • poor stream - R39.12 Poor urinary stream
      • psychogenic - F45.8 Other somatoform disorders
      • split stream - R39.13 Splitting of urinary stream
      • straining - R39.16 Straining to void
      • urgency - R39.15 Urgency of urination
    • mild neurocognitive - G31.84 Mild cognitive impairment, so stated
    • mitochondrial metabolism - E88.40 Mitochondrial metabolism disorder, unspecified
    • mitral (valve) - See: Endocarditis, mitral;
    • mixed
      • anxiety and depressive - F41.8 Other specified anxiety disorders
      • of scholastic skills (developmental) - F81.89 Other developmental disorders of scholastic skills
      • receptive expressive language - F80.2 Mixed receptive-expressive language disorder
    • mood - F39 Unspecified mood [affective] disorder
      • bipolar - See: Disorder, bipolar;
      • depressive - See: Disorder, depressive;
      • due to (secondary to)
        • alcohol - F10.94 Alcohol use, unspecified with alcohol-induced mood disorder
        • amphetamine - F15.94 Other stimulant use, unspecified with stimulant-induced mood disorder
          • in
            • abuse - F15.14 Other stimulant abuse with stimulant-induced mood disorder
            • dependence - F15.24 Other stimulant dependence with stimulant-induced mood disorder
        • anxiolytic - F13.94 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
          • in
            • abuse - F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
            • dependence - F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
        • cocaine - F14.94 Cocaine use, unspecified with cocaine-induced mood disorder
          • in
            • abuse - F14.14 Cocaine abuse with cocaine-induced mood disorder
            • dependence - F14.24 Cocaine dependence with cocaine-induced mood disorder
        • general medical condition - F06.30 Mood disorder due to known physiological condition, unspecified
        • hallucinogen - F16.94 Hallucinogen use, unspecified with hallucinogen-induced mood disorder
          • in
            • abuse - F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
            • dependence - F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder
        • hypnotic - F13.94 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
          • in
            • abuse - F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
            • dependence - F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
        • inhalant - F18.94 Inhalant use, unspecified with inhalant-induced mood disorder
          • in
            • abuse - F18.14 Inhalant abuse with inhalant-induced mood disorder
            • dependence - F18.24 Inhalant dependence with inhalant-induced mood disorder
        • opioid - F11.94 Opioid use, unspecified with opioid-induced mood disorder
          • in
            • abuse - F11.14 Opioid abuse with opioid-induced mood disorder
            • dependence - F11.24 Opioid dependence with opioid-induced mood disorder
        • phencyclidine (PCP) - F16.94 Hallucinogen use, unspecified with hallucinogen-induced mood disorder
          • in
            • abuse - F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
            • dependence - F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder
        • physiological condition - F06.30 Mood disorder due to known physiological condition, unspecified
          • with
            • depressive features - F06.31 Mood disorder due to known physiological condition with depressive features
            • major depressive-like episode - F06.32 Mood disorder due to known physiological condition with major depressive-like episode
            • manic features - F06.33 Mood disorder due to known physiological condition with manic features
            • mixed features - F06.34 Mood disorder due to known physiological condition with mixed features
        • psychoactive substance NEC - F19.94 Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder
          • in
            • abuse - F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
            • dependence - F19.24 Other psychoactive substance dependence with psychoactive substance-induced mood disorder
        • sedative - F13.94 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
          • in
            • abuse - F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
            • dependence - F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
        • volatile solvents - F18.94 Inhalant use, unspecified with inhalant-induced mood disorder
          • in
            • abuse - F18.14 Inhalant abuse with inhalant-induced mood disorder
            • dependence - F18.24 Inhalant dependence with inhalant-induced mood disorder
      • manic episode - F30.9 Manic episode, unspecified
        • in remission (full) - F30.4 Manic episode in full remission
          • partial - F30.3 Manic episode in partial remission
        • specified type NEC - F30.8 Other manic episodes
        • with psychotic symptoms - F30.2 Manic episode, severe with psychotic symptoms
        • without psychotic symptoms - F30.10 Manic episode without psychotic symptoms, unspecified
          • mild - F30.11 Manic episode without psychotic symptoms, mild
          • moderate - F30.12 Manic episode without psychotic symptoms, moderate
          • severe - F30.13 Manic episode, severe, without psychotic symptoms
      • organic - F06.30 Mood disorder due to known physiological condition, unspecified
        • right hemisphere - F07.89 Other personality and behavioral disorders due to known physiological condition
      • persistent - F34.9 Persistent mood [affective] disorder, unspecified
        • cyclothymia - F34.0 Cyclothymic disorder
        • dysthymia - F34.1 Dysthymic disorder
        • specified type NEC - F34.89 Other specified persistent mood disorders
      • recurrent - F39 Unspecified mood [affective] disorder
      • right hemisphere organic - F07.89 Other personality and behavioral disorders due to known physiological condition
    • movement - G25.9 Extrapyramidal and movement disorder, unspecified
      • drug-induced - G25.70 Drug induced movement disorder, unspecified
        • akathisia - G25.71 Drug induced akathisia
        • specified NEC - G25.79 Other drug induced movement disorders
      • hysterical - F44.4 Conversion disorder with motor symptom or deficit
      • in diseases classified elsewhere
      • periodic limb - G47.61 Periodic limb movement disorder
      • specified NEC - G25.89 Other specified extrapyramidal and movement disorders
      • stereotyped - F98.4 Stereotyped movement disorders
      • treatment-induced - G25.9 Extrapyramidal and movement disorder, unspecified
    • multiple personality - F44.81 Dissociative identity disorder
    • muscle - M62.9 Disorder of muscle, unspecified
      • attachment, spine - See: Enthesopathy, spinal;
      • in trichinellosis - See: Trichinellosis, with muscle disorder;
      • psychogenic - F45.8 Other somatoform disorders
      • specified type NEC - M62.89 Other specified disorders of muscle
      • tone, newborn - P94.9 Disorder of muscle tone of newborn, unspecified
        • specified NEC - P94.8 Other disorders of muscle tone of newborn
    • muscular
      • attachments - See Also: Enthesopathy;
        • spine - See: Enthesopathy, spinal;
      • urethra - N36.44 Muscular disorders of urethra
    • musculoskeletal system, soft tissue - See: Disorder, soft tissue;
      • postprocedural - M96.89 Other intraoperative and postprocedural complications and disorders of the musculoskeletal system
      • psychogenic - F45.8 Other somatoform disorders
    • myoneural - G70.9 Myoneural disorder, unspecified
      • due to lead - G70.1 Toxic myoneural disorders
      • specified NEC - G70.89 Other specified myoneural disorders
      • toxic - G70.1 Toxic myoneural disorders
    • myotonic NEC - G71.19 Other specified myotonic disorders
    • nail, in diseases classified elsewhere - L62 Nail disorders in diseases classified elsewhere
    • neck region NEC - See: Dorsopathy, specified NEC;
    • neonatal onset multisystemic inflammatory (NOMID) - M04.2 Cryopyrin-associated periodic syndromes
    • nerve - G58.9 Mononeuropathy, unspecified
      • abducent NEC - See: Strabismus, paralytic, sixth nerve;
      • accessory - G52.8 Disorders of other specified cranial nerves
      • acoustic
      • auditory
      • auriculotemporal - G50.8 Other disorders of trigeminal nerve
      • axillary - G54.0 Brachial plexus disorders
      • cerebral - See: Disorder, nerve, cranial;
      • cranial - G52.9 Cranial nerve disorder, unspecified
        • eighth
        • eleventh - G52.8 Disorders of other specified cranial nerves
        • fifth - G50.9 Disorder of trigeminal nerve, unspecified
        • first - G52.0 Disorders of olfactory nerve
        • fourth NEC - See: Strabismus, paralytic, fourth nerve;
        • multiple - G52.7 Disorders of multiple cranial nerves
        • ninth - G52.1 Disorders of glossopharyngeal nerve
        • second NEC - See: Disorder, nerve, optic;
        • seventh NEC - G51.8 Other disorders of facial nerve
        • sixth NEC - See: Strabismus, paralytic, sixth nerve;
        • specified NEC - G52.8 Disorders of other specified cranial nerves
        • tenth - G52.2 Disorders of vagus nerve
        • third NEC - See: Strabismus, paralytic, third nerve;
        • twelfth - G52.3 Disorders of hypoglossal nerve
      • entrapment - See: Neuropathy, entrapment;
      • facial - G51.9 Disorder of facial nerve, unspecified
        • specified NEC - G51.8 Other disorders of facial nerve
      • femoral - See: Lesion, nerve, femoral;
      • glossopharyngeal NEC - G52.1 Disorders of glossopharyngeal nerve
      • hypoglossal - G52.3 Disorders of hypoglossal nerve
      • intercostal - G58.0 Intercostal neuropathy
      • lateral
        • cutaneous of thigh - See: Mononeuropathy, lower limb, meralgia paresthetica;
        • popliteal - See: Lesion, nerve, popliteal;
      • lower limb - See: Mononeuropathy, lower limb;
      • medial popliteal - See: Lesion, nerve, popliteal, medial;
      • median NEC - See: Lesion, nerve, median;
      • multiple - G58.7 Mononeuritis multiplex
      • oculomotor NEC - See: Strabismus, paralytic, third nerve;
      • olfactory - G52.0 Disorders of olfactory nerve
      • optic NEC - H47.09 Other disorders of optic nerve, not elsewhere classified
        • hemorrhage into sheath - See: Hemorrhage, optic nerve;
        • ischemic - H47.01 Ischemic optic neuropathy
      • peroneal - See: Lesion, nerve, popliteal;
      • phrenic - G58.8 Other specified mononeuropathies
      • plantar - See: Lesion, nerve, plantar;
      • pneumogastric - G52.2 Disorders of vagus nerve
      • posterior tibial - See: Syndrome, tarsal tunnel;
      • radial - See: Lesion, nerve, radial;
      • recurrent laryngeal - G52.2 Disorders of vagus nerve
      • root - G54.9 Nerve root and plexus disorder, unspecified
        • cervical - G54.2 Cervical root disorders, not elsewhere classified
        • lumbosacral - G54.1 Lumbosacral plexus disorders
        • specified NEC - G54.8 Other nerve root and plexus disorders
        • thoracic - G54.3 Thoracic root disorders, not elsewhere classified
      • sciatic NEC - See: Lesion, nerve, sciatic;
      • specified NEC - G58.8 Other specified mononeuropathies
        • lower limb - See: Mononeuropathy, lower limb, specified NEC;
        • upper limb - See: Mononeuropathy, upper limb, specified NEC;
      • sympathetic - G90.9 Disorder of the autonomic nervous system, unspecified
      • tibial - See: Lesion, nerve, popliteal, medial;
      • trigeminal - G50.9 Disorder of trigeminal nerve, unspecified
        • specified NEC - G50.8 Other disorders of trigeminal nerve
      • trochlear NEC - See: Strabismus, paralytic, fourth nerve;
      • ulnar - See: Lesion, nerve, ulnar;
      • upper limb - See: Mononeuropathy, upper limb;
      • vagus - G52.2 Disorders of vagus nerve
    • nervous system - G98.8 Other disorders of nervous system
      • autonomic (peripheral) - G90.9 Disorder of the autonomic nervous system, unspecified
        • specified NEC - G90.8 Other disorders of autonomic nervous system
      • central - G96.9 Disorder of central nervous system, unspecified
        • specified NEC - G96.8 Other specified disorders of central nervous system
      • parasympathetic - G90.9 Disorder of the autonomic nervous system, unspecified
      • specified NEC - G98.8 Other disorders of nervous system
      • sympathetic - G90.9 Disorder of the autonomic nervous system, unspecified
      • vegetative - G90.9 Disorder of the autonomic nervous system, unspecified
    • neurocognitive - R41.9 Unspecified symptoms and signs involving cognitive functions and awareness
      • major
        • due to vascular disease, with behavioral disturbance - F01.51 Vascular dementia with behavioral disturbance
        • in (due to) (other diseases classified elsewhere) - See Also: Dementia, in (due to); - F02.80 Dementia in other diseases classified elsewhere without behavioral disturbance
          • with
            • aggressive behavior - F02.81 Dementia in other diseases classified elsewhere with behavioral disturbance
            • combative behavior - F02.81 Dementia in other diseases classified elsewhere with behavioral disturbance
            • violent behavior - F02.81 Dementia in other diseases classified elsewhere with behavioral disturbance
        • with
          • aggressive behavior - F01.51 Vascular dementia with behavioral disturbance
          • combative behavior - F01.51 Vascular dementia with behavioral disturbance
          • violent behavior - F01.51 Vascular dementia with behavioral disturbance
        • without behavioral disturbance - F01.50 Vascular dementia without behavioral disturbance
      • mild - G31.84 Mild cognitive impairment, so stated
    • neurodevelopmental - F89 Unspecified disorder of psychological development
      • specified NEC - F88 Other disorders of psychological development
    • neurohypophysis NEC - E23.3 Hypothalamic dysfunction, not elsewhere classified
    • neurological NEC - R29.818 Other symptoms and signs involving the nervous system
    • neuromuscular - G70.9 Myoneural disorder, unspecified
      • hereditary NEC - G71.9 Primary disorder of muscle, unspecified
      • specified NEC - G70.89 Other specified myoneural disorders
      • toxic - G70.1 Toxic myoneural disorders
    • neurotic - F48.9 Nonpsychotic mental disorder, unspecified
      • specified NEC - F48.8 Other specified nonpsychotic mental disorders
    • neutrophil, polymorphonuclear - D71 Functional disorders of polymorphonuclear neutrophils
    • nicotine use - See: Dependence, drug, nicotine;
    • nightmare - F51.5 Nightmare disorder
    • non-rapid eye movement sleep arousal
      • sleep terror type - F51.4 Sleep terrors [night terrors]
      • sleepwalking type - F51.3 Sleepwalking [somnambulism]
    • nose - J34.9 Unspecified disorder of nose and nasal sinuses
      • specified NEC - J34.89 Other specified disorders of nose and nasal sinuses
    • obsessive-compulsive - F42.9 Obsessive-compulsive disorder, unspecified
    • odontogenesis NOS - K00.9 Disorder of tooth development, unspecified
    • opioid use
      • due to drug abuse - See: Abuse, drug, opioid;
      • due to drug dependence - See: Dependence, drug, opioid;
      • mild - F11.10 Opioid abuse, uncomplicated
        • in remission (early) (sustained) - F11.11 Opioid abuse, in remission
        • with
          • opioid intoxication
            • delirium - F11.121 Opioid abuse with intoxication delirium
            • with perceptual disturbances - F11.122 Opioid abuse with intoxication with perceptual disturbance
            • without perceptual disturbances - F11.129 Opioid abuse with intoxication, unspecified
          • opioid-induced
            • anxiety disorder - F11.188 Opioid abuse with other opioid-induced disorder
            • depressive disorder - F11.14 Opioid abuse with opioid-induced mood disorder
            • sexual dysfunction - F11.181 Opioid abuse with opioid-induced sexual dysfunction
      • moderate or severe - F11.20 Opioid dependence, uncomplicated
        • in remission (early) (sustained) - F11.21 Opioid dependence, in remission
        • with
          • opioid intoxication
            • delirium - F11.221 Opioid dependence with intoxication delirium
            • with perceptual disturbances - F11.222 Opioid dependence with intoxication with perceptual disturbance
            • without perceptual disturbances - F11.229 Opioid dependence with intoxication, unspecified
          • opioid-induced
            • anxiety disorder - F11.288 Opioid dependence with other opioid-induced disorder
            • anxiety disorder - F11.988 Opioid use, unspecified with other opioid-induced disorder
            • depressive disorder - F11.24 Opioid dependence with opioid-induced mood disorder
            • depressive disorder - F11.94 Opioid use, unspecified with opioid-induced mood disorder
            • sexual dysfunction - F11.281 Opioid dependence with opioid-induced sexual dysfunction
            • sexual dysfunction - F11.981 Opioid use, unspecified with opioid-induced sexual dysfunction
      • with
        • opioid-induced psychotic disorder - F11.959 Opioid use, unspecified with opioid-induced psychotic disorder, unspecified
          • with
            • delusions - F11.950 Opioid use, unspecified with opioid-induced psychotic disorder with delusions
            • hallucinations - F11.951 Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations
    • oppositional defiant - F91.3 Oppositional defiant disorder
    • optic
      • chiasm - H47.49 Disorders of optic chiasm in (due to) other disorders
        • due to
          • inflammatory disorder - H47.41 Disorders of optic chiasm in (due to) inflammatory disorders
          • neoplasm - H47.42 Disorders of optic chiasm in (due to) neoplasm
          • vascular disorder - H47.43 Disorders of optic chiasm in (due to) vascular disorders
      • disc - H47.39 Other disorders of optic disc
        • coloboma - See: Coloboma, optic disc;
        • drusen - See: Drusen, optic disc;
        • pseudopapilledema - See: Pseudopapilledema;
      • radiations - See: Disorder, visual, pathway;
      • tracts - See: Disorder, visual, pathway;
    • orbit - H05.9 Unspecified disorder of orbit
      • cyst - See: Cyst, orbit;
      • deformity - See: Deformity, orbit;
      • edema - See: Edema, orbit;
      • enophthalmos - See: Enophthalmos;
      • exophthalmos - See: Exophthalmos;
      • hemorrhage - See: Hemorrhage, orbit;
      • inflammation - See: Inflammation, orbit;
      • myopathy - See: Myopathy, extraocular muscles;
      • retained foreign body - See: Foreign body, orbit, old;
      • specified type NEC - H05.89 Other disorders of orbit
    • organic
      • anxiety - F06.4 Anxiety disorder due to known physiological condition
      • catatonic - F06.1 Catatonic disorder due to known physiological condition
      • delusional - F06.2 Psychotic disorder with delusions due to known physiological condition
      • dissociative - F06.8 Other specified mental disorders due to known physiological condition
      • emotionally labile (asthenic) - F06.8 Other specified mental disorders due to known physiological condition
      • mood (affective) - F06.30 Mood disorder due to known physiological condition, unspecified
      • schizophrenia-like - F06.2 Psychotic disorder with delusions due to known physiological condition
    • orgasmic (female) - F52.31 Female orgasmic disorder
      • male - F52.32 Male orgasmic disorder
    • ornithine metabolism - E72.4 Disorders of ornithine metabolism
    • overanxious - F41.1 Generalized anxiety disorder
      • of childhood - F93.8 Other childhood emotional disorders
    • pain
      • genito-pelvic penetration disorder - F52.6 Dyspareunia not due to a substance or known physiological condition
    • pancreatic internal secretion - E16.9 Disorder of pancreatic internal secretion, unspecified
      • specified NEC - E16.8 Other specified disorders of pancreatic internal secretion
    • panic - F41.0 Panic disorder [episodic paroxysmal anxiety]
      • with agoraphobia - F40.01 Agoraphobia with panic disorder
    • papulosquamous - L44.9 Papulosquamous disorder, unspecified
      • in diseases classified elsewhere - L45 Papulosquamous disorders in diseases classified elsewhere
      • specified NEC - L44.8 Other specified papulosquamous disorders
    • paranoid - F22 Delusional disorders
      • induced - F24 Shared psychotic disorder
      • shared - F24 Shared psychotic disorder
    • paraphilic - F65.9 Paraphilia, unspecified
      • specified NEC - F65.89 Other paraphilias
    • parathyroid (gland) - E21.5 Disorder of parathyroid gland, unspecified
      • specified NEC - E21.4 Other specified disorders of parathyroid gland
    • parietoalveolar NEC - J84.09 Other alveolar and parieto-alveolar conditions
    • paroxysmal, mixed - R56.9 Unspecified convulsions
    • patella - M22.9 Unspecified disorder of patella
      • chondromalacia - See: Chondromalacia, patella;
      • derangement NEC - M22.3X Other derangements of patella
      • recurrent
        • dislocation - See: Dislocation, patella, recurrent;
        • subluxation - See: Dislocation, patella, recurrent, incomplete;
      • specified NEC - M22.8X Other disorders of patella
    • patellofemoral - M22.2X Patellofemoral disorders
    • pedophilic - F65.4 Pedophilia
    • pentose phosphate pathway with anemia - D55.1 Anemia due to other disorders of glutathione metabolism
    • perception, due to hallucinogens - F16.983 Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
      • in
        • abuse - F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
        • dependence - F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
    • peripheral nervous system NEC - G64 Other disorders of peripheral nervous system
    • peroxisomal - E71.50 Peroxisomal disorder, unspecified
      • biogenesis
        • neonatal adrenoleukodystrophy - E71.511 Neonatal adrenoleukodystrophy
        • specified disorder NEC - E71.518 Other disorders of peroxisome biogenesis
        • Zellweger syndrome - E71.510 Zellweger syndrome
      • rhizomelic chondrodysplasia punctata - E71.540 Rhizomelic chondrodysplasia punctata
      • specified form NEC - E71.548 Other peroxisomal disorders
        • group 1 - E71.518 Other disorders of peroxisome biogenesis
        • group 2 - E71.53 Other group 2 peroxisomal disorders
        • group 3 - E71.542 Other group 3 peroxisomal disorders
      • X-linked adrenoleukodystrophy - E71.529 X-linked adrenoleukodystrophy, unspecified type
        • adolescent - E71.521 Adolescent X-linked adrenoleukodystrophy
        • adrenomyeloneuropathy - E71.522 Adrenomyeloneuropathy
        • childhood - E71.520 Childhood cerebral X-linked adrenoleukodystrophy
        • specified form NEC - E71.528 Other X-linked adrenoleukodystrophy
      • Zellweger-like syndrome - E71.541 Zellweger-like syndrome
    • persistent
      • (somatoform) pain - F45.41 Pain disorder exclusively related to psychological factors
      • affective (mood) - F34.9 Persistent mood [affective] disorder, unspecified
    • personality - See Also: Personality; - F60.9 Personality disorder, unspecified
      • affective - F34.0 Cyclothymic disorder
      • aggressive - F60.3 Borderline personality disorder
      • amoral - F60.2 Antisocial personality disorder
      • anankastic - F60.5 Obsessive-compulsive personality disorder
      • antisocial - F60.2 Antisocial personality disorder
      • anxious - F60.6 Avoidant personality disorder
      • asocial - F60.2 Antisocial personality disorder
      • asthenic - F60.7 Dependent personality disorder
      • avoidant - F60.6 Avoidant personality disorder
      • borderline - F60.3 Borderline personality disorder
      • change (secondary) due to general medical condition - F07.0 Personality change due to known physiological condition
      • compulsive - F60.5 Obsessive-compulsive personality disorder
      • cyclothymic - F34.0 Cyclothymic disorder
      • dependent (passive) - F60.7 Dependent personality disorder
      • depressive - F34.1 Dysthymic disorder
      • dissocial - F60.2 Antisocial personality disorder
      • emotional instability - F60.3 Borderline personality disorder
      • expansive paranoid - F60.0 Paranoid personality disorder
      • explosive - F60.3 Borderline personality disorder
      • following organic brain damage - F07.9 Unspecified personality and behavioral disorder due to known physiological condition
      • histrionic - F60.4 Histrionic personality disorder
      • hyperthymic - F34.0 Cyclothymic disorder
      • hypothymic - F34.1 Dysthymic disorder
      • hysterical - F60.4 Histrionic personality disorder
      • immature - F60.89 Other specific personality disorders
      • inadequate - F60.7 Dependent personality disorder
      • labile - F60.3 Borderline personality disorder
      • mixed (nonspecific) - F60.89 Other specific personality disorders
      • moral deficiency - F60.2 Antisocial personality disorder
      • narcissistic - F60.81 Narcissistic personality disorder
      • negativistic - F60.89 Other specific personality disorders
      • obsessional - F60.5 Obsessive-compulsive personality disorder
      • obsessive (-compulsive) - F60.5 Obsessive-compulsive personality disorder
      • organic - F07.9 Unspecified personality and behavioral disorder due to known physiological condition
      • overconscientious - F60.5 Obsessive-compulsive personality disorder
      • paranoid - F60.0 Paranoid personality disorder
      • passive (-dependent) - F60.7 Dependent personality disorder
      • passive-aggressive - F60.89 Other specific personality disorders
      • pathological NEC - F60.9 Personality disorder, unspecified
      • pseudosocial - F60.2 Antisocial personality disorder
      • psychopathic - F60.2 Antisocial personality disorder
      • schizoid - F60.1 Schizoid personality disorder
      • schizotypal - F21 Schizotypal disorder
      • self-defeating - F60.7 Dependent personality disorder
      • specified NEC - F60.89 Other specific personality disorders
      • type A - F60.5 Obsessive-compulsive personality disorder
      • unstable (emotional) - F60.3 Borderline personality disorder
    • pervasive, developmental - F84.9 Pervasive developmental disorder, unspecified
    • phencyclidine use
      • mild - F16.10 Hallucinogen abuse, uncomplicated
        • in remission (early) (sustained) - F16.11 Hallucinogen abuse, in remission
        • with
          • phencyclidine intoxication - F16.129 Hallucinogen abuse with intoxication, unspecified
          • phencyclidine intoxication delirium - F16.121 Hallucinogen abuse with intoxication with delirium
          • phencyclidine-induced
            • anxiety disorder - F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
            • depressive disorder - F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
            • psychotic disorder - F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
      • moderate or severe - F16.20 Hallucinogen dependence, uncomplicated
        • in remission (early) (sustained) - F16.21 Hallucinogen dependence, in remission
        • with
          • phencyclidine intoxication - F16.229 Hallucinogen dependence with intoxication, unspecified
          • phencyclidine intoxication delirium - F16.221 Hallucinogen dependence with intoxication with delirium
          • phencyclidine-induced
            • anxiety disorder - F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
            • depressive disorder - F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder
            • psychotic disorder - F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
    • phobic anxiety, childhood - F40.8 Other phobic anxiety disorders
    • phosphate-losing tubular - N25.0 Renal osteodystrophy
    • pigmentation - L81.9 Disorder of pigmentation, unspecified
      • choroid, congenital - Q14.3 Congenital malformation of choroid
      • diminished melanin formation - L81.6 Other disorders of diminished melanin formation
      • iron - L81.8 Other specified disorders of pigmentation
      • specified NEC - L81.8 Other specified disorders of pigmentation
    • pinna (noninfective) - H61.10 Unspecified noninfective disorders of pinna
      • deformity, acquired - H61.11 Acquired deformity of pinna
      • hematoma - H61.12 Hematoma of pinna
      • perichondritis - See: Perichondritis, ear;
      • specified type NEC - H61.19 Other noninfective disorders of pinna
    • pituitary gland - E23.7 Disorder of pituitary gland, unspecified
      • iatrogenic (postprocedural) - E89.3 Postprocedural hypopituitarism
      • specified NEC - E23.6 Other disorders of pituitary gland
    • platelets - D69.1 Qualitative platelet defects
    • plexus - G54.9 Nerve root and plexus disorder, unspecified
      • specified NEC - G54.8 Other nerve root and plexus disorders
    • polymorphonuclear neutrophils - D71 Functional disorders of polymorphonuclear neutrophils
    • porphyrin metabolism - See: Porphyria;
    • postconcussional - F07.81 Postconcussional syndrome
    • posthallucinogen perception - F16.983 Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
      • in
        • abuse - F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
        • dependence - F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
    • postmenopausal - N95.9 Unspecified menopausal and perimenopausal disorder
      • specified NEC - N95.8 Other specified menopausal and perimenopausal disorders
    • postprocedural (postoperative) - See: Complications, postprocedural;
    • post-transplant lymphoproliferative - D47.Z1 Post-transplant lymphoproliferative disorder (PTLD)
    • post-traumatic stress (PTSD) - F43.10 Post-traumatic stress disorder, unspecified
      • acute - F43.11 Post-traumatic stress disorder, acute
      • chronic - F43.12 Post-traumatic stress disorder, chronic
    • premenstrual dysphoric (PMDD) - F32.81 Premenstrual dysphoric disorder
    • prepuce - N47.8 Other disorders of prepuce
    • propionic acidemia - E71.121 Propionic acidemia
    • prostate - N42.9 Disorder of prostate, unspecified
      • specified NEC - N42.89 Other specified disorders of prostate
    • psychogenic NOS - See Also: condition; - F45.9 Somatoform disorder, unspecified
      • anxiety - F41.8 Other specified anxiety disorders
      • appetite - F50.9 Eating disorder, unspecified
      • asthenic - F48.8 Other specified nonpsychotic mental disorders
      • cardiovascular (system) - F45.8 Other somatoform disorders
      • compulsive - F42.8 Other obsessive-compulsive disorder
      • cutaneous - F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere
      • depressive - F32.9 Major depressive disorder, single episode, unspecified
      • digestive (system) - F45.8 Other somatoform disorders
      • dysmenorrheic - F45.8 Other somatoform disorders
      • dyspneic - F45.8 Other somatoform disorders
      • endocrine (system) - F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere
      • eye NEC - F45.8 Other somatoform disorders
      • feeding - See: Disorder, eating;
      • functional NEC - F45.8 Other somatoform disorders
      • gastric - F45.8 Other somatoform disorders
      • gastrointestinal (system) - F45.8 Other somatoform disorders
      • genitourinary (system) - F45.8 Other somatoform disorders
      • heart (function) (rhythm) - F45.8 Other somatoform disorders
      • hyperventilatory - F45.8 Other somatoform disorders
      • hypochondriacal - See: Disorder, hypochondriacal;
      • intestinal - F45.8 Other somatoform disorders
      • joint - F45.8 Other somatoform disorders
      • learning - F81.9 Developmental disorder of scholastic skills, unspecified
      • limb - F45.8 Other somatoform disorders
      • lymphatic (system) - F45.8 Other somatoform disorders
      • menstrual - F45.8 Other somatoform disorders
      • micturition - F45.8 Other somatoform disorders
      • monoplegic NEC - F44.4 Conversion disorder with motor symptom or deficit
      • motor - F44.4 Conversion disorder with motor symptom or deficit
      • muscle - F45.8 Other somatoform disorders
      • musculoskeletal - F45.8 Other somatoform disorders
      • neurocirculatory - F45.8 Other somatoform disorders
      • obsessive - F42.8 Other obsessive-compulsive disorder
      • occupational - F48.8 Other specified nonpsychotic mental disorders
      • organ or part of body NEC - F45.8 Other somatoform disorders
      • paralytic NEC - F44.4 Conversion disorder with motor symptom or deficit
      • phobic - F40.9 Phobic anxiety disorder, unspecified
      • physical NEC - F45.8 Other somatoform disorders
      • rectal - F45.8 Other somatoform disorders
      • respiratory (system) - F45.8 Other somatoform disorders
      • rheumatic - F45.8 Other somatoform disorders
      • sexual (function) - F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
      • skin (allergic) (eczematous) - F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere
      • sleep - F51.9 Sleep disorder not due to a substance or known physiological condition, unspecified
      • specified part of body NEC - F45.8 Other somatoform disorders
      • stomach - F45.8 Other somatoform disorders
    • psychological - F99 Mental disorder, not otherwise specified
      • associated with
        • disease classified elsewhere - F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere
        • sexual
          • development - F66 Other sexual disorders
          • relationship - F66 Other sexual disorders
        • uncertainty about gender identity - F64.9 Gender identity disorder, unspecified
    • psychomotor NEC - F44.4 Conversion disorder with motor symptom or deficit
      • hysterical - F44.4 Conversion disorder with motor symptom or deficit
    • psychoneurotic - See Also: Neurosis;
      • mixed NEC - F48.8 Other specified nonpsychotic mental disorders
    • psychophysiologic - See: Disorder, somatoform;
    • psychosexual - F65.9 Paraphilia, unspecified
      • development - F66 Other sexual disorders
      • identity of childhood - F64.2 Gender identity disorder of childhood
    • psychosomatic NOS - See: Disorder, somatoform;
      • multiple - F45.0 Somatization disorder
      • undifferentiated - F45.1 Undifferentiated somatoform disorder
    • psychotic - See: Psychosis;
      • transient (acute) - F23 Brief psychotic disorder
    • puberty - E30.9 Disorder of puberty, unspecified
      • specified NEC - E30.8 Other disorders of puberty
    • pulmonary (valve) - See: Endocarditis, pulmonary;
    • purine metabolism - E79.9 Disorder of purine and pyrimidine metabolism, unspecified
    • pyrimidine metabolism - E79.9 Disorder of purine and pyrimidine metabolism, unspecified
    • pyruvate metabolism - E74.4 Disorders of pyruvate metabolism and gluconeogenesis
    • reactive attachment (childhood) - F94.1 Reactive attachment disorder of childhood
    • reading - R48.0 Dyslexia and alexia
      • developmental (specific) - F81.0 Specific reading disorder
    • receptive language - F80.2 Mixed receptive-expressive language disorder
    • receptor, hormonal, peripheral - See Also: Syndrome, androgen insensitivity; - E34.50 Androgen insensitivity syndrome, unspecified
    • recurrent brief depressive - F33.8 Other recurrent depressive disorders
    • reflex - R29.2 Abnormal reflex
    • refraction - H52.7 Unspecified disorder of refraction
      • aniseikonia - H52.32 Aniseikonia
      • anisometropia - H52.31 Anisometropia
      • astigmatism - See: Astigmatism;
      • hypermetropia - See: Hypermetropia;
      • myopia - See: Myopia;
      • presbyopia - H52.4 Presbyopia
      • specified NEC - H52.6 Other disorders of refraction
    • relationship - F68.8 Other specified disorders of adult personality and behavior
      • due to sexual orientation - F66 Other sexual disorders
    • REM sleep behavior - G47.52 REM sleep behavior disorder
    • renal function, impaired (tubular) - N25.9 Disorder resulting from impaired renal tubular function, unspecified
    • resonance - R49.9 Unspecified voice and resonance disorder
      • specified NEC - R49.8 Other voice and resonance disorders
    • respiratory function, impaired - See Also: Failure, respiration;
      • postprocedural - See: Complication, postoperative, respiratory system;
      • psychogenic - F45.8 Other somatoform disorders
    • retina - H35.9 Unspecified retinal disorder
      • angioid streaks - H35.33 Angioid streaks of macula
      • changes in vascular appearance - H35.01 Changes in retinal vascular appearance
      • degeneration - See: Degeneration, retina;
      • dystrophy (hereditary) - See: Dystrophy, retina;
      • edema - H35.81 Retinal edema
      • hemorrhage - See: Hemorrhage, retina;
      • ischemia - H35.82 Retinal ischemia
      • macular degeneration - See: Degeneration, macula;
      • microaneurysms - H35.04 Retinal micro-aneurysms, unspecified
      • microvascular abnormality NEC - H35.09 Other intraretinal microvascular abnormalities
      • neovascularization - See: Neovascularization, retina;
      • retinopathy - See: Retinopathy;
      • separation of layers - H35.70 Unspecified separation of retinal layers
        • central serous chorioretinopathy - H35.71 Central serous chorioretinopathy
        • pigment epithelium detachment (serous) - H35.72 Serous detachment of retinal pigment epithelium
          • hemorrhagic - H35.73 Hemorrhagic detachment of retinal pigment epithelium
      • specified type NEC - H35.89 Other specified retinal disorders
      • telangiectasis - See: Telangiectasis, retina;
      • vasculitis - See: Vasculitis, retina;
    • retroperitoneal - K68.9 Other disorders of retroperitoneum
    • right hemisphere organic affective - F07.89 Other personality and behavioral disorders due to known physiological condition
    • rumination (infant or child) - F98.21 Rumination disorder of infancy
    • sacrum, sacrococcygeal NEC - M53.3 Sacrococcygeal disorders, not elsewhere classified
    • schizoaffective - F25.9 Schizoaffective disorder, unspecified
      • bipolar type - F25.0 Schizoaffective disorder, bipolar type
      • depressive type - F25.1 Schizoaffective disorder, depressive type
      • manic type - F25.0 Schizoaffective disorder, bipolar type
      • mixed type - F25.0 Schizoaffective disorder, bipolar type
      • specified NEC - F25.8 Other schizoaffective disorders
    • schizoid of childhood - F84.5 Asperger's syndrome
    • schizophrenia spectrum and other psychotic disorder - F29 Unspecified psychosis not due to a substance or known physiological condition
      • specified NEC - F28 Other psychotic disorder not due to a substance or known physiological condition
    • schizophreniform - F20.81 Schizophreniform disorder
      • brief - F23 Brief psychotic disorder
    • schizotypal (personality) - F21 Schizotypal disorder
    • secretion, thyrocalcitonin - E07.0 Hypersecretion of calcitonin
    • sedative, hypnotic, or anxiolytic use
      • mild - F13.10 Sedative, hypnotic or anxiolytic abuse, uncomplicated
        • in remission (early) (sustained) - F13.11 Sedative, hypnotic or anxiolytic abuse, in remission
        • with
          • sedative, hypnotic, or anxiolytic intoxication - F13.129 Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
          • sedative, hypnotic, or anxiolytic intoxication delirium - F13.121 Sedative, hypnotic or anxiolytic abuse with intoxication delirium
          • sedative, hypnotic, or anxiolytic-induced
            • anxiety disorder - F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
            • depressive disorder - F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
            • psychotic disorder - F13.159 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
            • sexual dysfunction - F13.181 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction
      • moderate or severe - F13.20 Sedative, hypnotic or anxiolytic dependence, uncomplicated
        • in remission (early) (sustained) - F13.21 Sedative, hypnotic or anxiolytic dependence, in remission
        • with
          • sedative, hypnotic, or anxiolytic intoxication - F13.229 Sedative, hypnotic or anxiolytic dependence with intoxication, unspecified
          • sedative, hypnotic, or anxiolytic intoxication delirium - F13.221 Sedative, hypnotic or anxiolytic dependence with intoxication delirium
          • sedative, hypnotic, or anxiolytic-induced
            • anxiety disorder - F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
            • depressive disorder - F13.24 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced mood disorder
            • major neurocognitive disorder - F13.27 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced persisting dementia
            • mild neurocognitive disorder - F13.288 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder
            • psychotic disorder - F13.259 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
            • sexual dysfunction - F13.281 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
    • seizure - See Also: Epilepsy; - G40.909 Epilepsy, unspecified, not intractable, without status epilepticus
      • intractable - G40.919 Epilepsy, unspecified, intractable, without status epilepticus
        • with status epilepticus - G40.911 Epilepsy, unspecified, intractable, with status epilepticus
    • semantic pragmatic - F80.89 Other developmental disorders of speech and language
      • with autism - F84.0 Autistic disorder
    • sense of smell - R43.1 Parosmia
      • psychogenic - F45.8 Other somatoform disorders
    • separation anxiety, of childhood - F93.0 Separation anxiety disorder of childhood
    • sexual
      • arousal, female - F52.22 Female sexual arousal disorder
      • aversion - F52.1 Sexual aversion disorder
      • function, psychogenic - F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
      • interest/arousal, female - F52.22 Female sexual arousal disorder
      • masochism - F65.51 Sexual masochism
      • maturation - F66 Other sexual disorders
      • nonorganic - F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
      • preference - See Also: Deviation, sexual; - F65.9 Paraphilia, unspecified
        • fetishistic transvestism - F65.1 Transvestic fetishism
      • relationship - F66 Other sexual disorders
      • sadism - F65.52 Sexual sadism
    • shyness, of childhood and adolescence - F40.10 Social phobia, unspecified
    • sibling rivalry - F93.8 Other childhood emotional disorders
    • sickle-cell (sickling) (homozygous) - See: Disease, sickle-cell;
      • heterozygous - D57.3 Sickle-cell trait
      • specified type NEC - D57.8 Other sickle-cell disorders
      • trait - D57.3 Sickle-cell trait
    • sinus (nasal) - J34.9 Unspecified disorder of nose and nasal sinuses
      • specified NEC - J34.89 Other specified disorders of nose and nasal sinuses
    • skin - L98.9 Disorder of the skin and subcutaneous tissue, unspecified
      • atrophic - L90.9 Atrophic disorder of skin, unspecified
        • specified NEC - L90.8 Other atrophic disorders of skin
      • granulomatous - L92.9 Granulomatous disorder of the skin and subcutaneous tissue, unspecified
        • specified NEC - L92.8 Other granulomatous disorders of the skin and subcutaneous tissue
      • hypertrophic - L91.9 Hypertrophic disorder of the skin, unspecified
        • specified NEC - L91.8 Other hypertrophic disorders of the skin
      • infiltrative NEC - L98.6 Other infiltrative disorders of the skin and subcutaneous tissue
      • newborn - P83.9 Condition of the integument specific to newborn, unspecified
        • specified NEC - P83.88 Other specified conditions of integument specific to newborn
      • picking - F42.4 Excoriation (skin-picking) disorder
      • psychogenic (allergic) (eczematous) - F54 Psychological and behavioral factors associated with disorders or diseases classified elsewhere
    • sleep - G47.9 Sleep disorder, unspecified
      • circadian rhythm - G47.20 Circadian rhythm sleep disorder, unspecified type
        • advance sleep phase type - G47.22 Circadian rhythm sleep disorder, advanced sleep phase type
        • delayed sleep phase type - G47.21 Circadian rhythm sleep disorder, delayed sleep phase type
        • due to
          • alcohol
            • abuse - F10.182 Alcohol abuse with alcohol-induced sleep disorder
            • dependence - F10.282 Alcohol dependence with alcohol-induced sleep disorder
            • use - F10.982 Alcohol use, unspecified with alcohol-induced sleep disorder
          • amphetamines
            • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
            • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
            • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
          • caffeine
            • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
            • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
            • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
          • cocaine
            • abuse - F14.182 Cocaine abuse with cocaine-induced sleep disorder
            • dependence - F14.282 Cocaine dependence with cocaine-induced sleep disorder
            • use - F14.982 Cocaine use, unspecified with cocaine-induced sleep disorder
          • drug NEC
            • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
            • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
            • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
          • opioid
            • abuse - F11.182 Opioid abuse with opioid-induced sleep disorder
            • dependence - F11.282 Opioid dependence with opioid-induced sleep disorder
            • use - F11.982 Opioid use, unspecified with opioid-induced sleep disorder
          • psychoactive substance NEC
            • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
            • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
            • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
          • sedative, hypnotic, or anxiolytic
            • abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
            • dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
            • use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
          • stimulant NEC
            • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
            • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
            • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
        • free running type - G47.24 Circadian rhythm sleep disorder, free running type
        • in conditions classified elsewhere - G47.27 Circadian rhythm sleep disorder in conditions classified elsewhere
        • irregular sleep wake type - G47.23 Circadian rhythm sleep disorder, irregular sleep wake type
        • jet lag type - G47.25 Circadian rhythm sleep disorder, jet lag type
        • non-24-hour sleep-wake type - G47.24 Circadian rhythm sleep disorder, free running type
        • shift work type - G47.26 Circadian rhythm sleep disorder, shift work type
        • specified NEC - G47.29 Other circadian rhythm sleep disorder
      • due to
        • alcohol
          • abuse - F10.182 Alcohol abuse with alcohol-induced sleep disorder
          • dependence - F10.282 Alcohol dependence with alcohol-induced sleep disorder
          • use - F10.982 Alcohol use, unspecified with alcohol-induced sleep disorder
        • amphetamine
          • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
          • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
          • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
        • anxiolytic
          • abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
          • dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
          • use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
        • caffeine
          • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
          • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
          • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
        • cocaine
          • abuse - F14.182 Cocaine abuse with cocaine-induced sleep disorder
          • dependence - F14.282 Cocaine dependence with cocaine-induced sleep disorder
          • use - F14.982 Cocaine use, unspecified with cocaine-induced sleep disorder
        • drug NEC
          • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
          • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
          • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
        • hypnotic
          • abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
          • dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
          • use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
        • opioid
          • abuse - F11.182 Opioid abuse with opioid-induced sleep disorder
          • dependence - F11.282 Opioid dependence with opioid-induced sleep disorder
          • use - F11.982 Opioid use, unspecified with opioid-induced sleep disorder
        • psychoactive substance NEC
          • abuse - F19.182 Other psychoactive substance abuse with psychoactive substance-induced sleep disorder
          • dependence - F19.282 Other psychoactive substance dependence with psychoactive substance-induced sleep disorder
          • use - F19.982 Other psychoactive substance use, unspecified with psychoactive substance-induced sleep disorder
        • sedative
          • abuse - F13.182 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
          • dependence - F13.282 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
          • use - F13.982 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
        • stimulant NEC
          • abuse - F15.182 Other stimulant abuse with stimulant-induced sleep disorder
          • dependence - F15.282 Other stimulant dependence with stimulant-induced sleep disorder
          • use - F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorder
      • emotional - F51.9 Sleep disorder not due to a substance or known physiological condition, unspecified
      • excessive somnolence - See: Hypersomnia;
      • hypersomnia type - See: Hypersomnia;
      • initiating or maintaining - See: Insomnia;
      • nightmares - F51.5 Nightmare disorder
      • nonorganic - F51.9 Sleep disorder not due to a substance or known physiological condition, unspecified
        • specified NEC - F51.8 Other sleep disorders not due to a substance or known physiological condition
      • parasomnia type - G47.50 Parasomnia, unspecified
      • specified NEC - G47.8 Other sleep disorders
      • terrors - F51.4 Sleep terrors [night terrors]
      • walking - F51.3 Sleepwalking [somnambulism]
    • sleep-wake pattern or schedule - See Also: Disorder, sleep, circadian rhythm; - G47.9 Sleep disorder, unspecified
      • specified NEC - G47.8 Other sleep disorders
    • social
      • anxiety (of childhood) - F40.10 Social phobia, unspecified
        • generalized - F40.11 Social phobia, generalized
      • functioning in childhood - F94.9 Childhood disorder of social functioning, unspecified
        • specified NEC - F94.8 Other childhood disorders of social functioning
      • pragmatic - F80.82 Social pragmatic communication disorder
    • soft tissue - M79.9 Soft tissue disorder, unspecified
      • ankle - M79.9 Soft tissue disorder, unspecified
      • due to use, overuse and pressure - M70.90 Unspecified soft tissue disorder related to use, overuse and pressure of unspecified site
        • ankle - M70.97 Unspecified soft tissue disorder related to use, overuse and pressure of ankle and foot
        • bursitis - See: Bursitis;
        • foot - M70.97 Unspecified soft tissue disorder related to use, overuse and pressure of ankle and foot
        • forearm - M70.93 Unspecified soft tissue disorder related to use, overuse and pressure of forearm
        • hand - M70.94 Unspecified soft tissue disorder related to use, overuse and pressure of hand
        • lower leg - M70.96 Unspecified soft tissue disorder related to use, overuse and pressure lower leg
        • multiple sites - M70.99 Unspecified soft tissue disorder related to use, overuse and pressure multiple sites
        • pelvic region - M70.95 Unspecified soft tissue disorder related to use, overuse and pressure of thigh
        • shoulder region - M70.91 Unspecified soft tissue disorder related to use, overuse and pressure of shoulder
        • specified site NEC - M70.98 Unspecified soft tissue disorder related to use, overuse and pressure other
        • specified type NEC - M70.80 Other soft tissue disorders related to use, overuse and pressure of unspecified site
          • ankle - M70.87 Other soft tissue disorders related to use, overuse and pressure of ankle and foot
          • foot - M70.87 Other soft tissue disorders related to use, overuse and pressure of ankle and foot
          • forearm - M70.83 Other soft tissue disorders related to use, overuse and pressure of forearm
          • hand - M70.84 Other soft tissue disorders related to use, overuse and pressure of hand
          • lower leg - M70.86 Other soft tissue disorders related to use, overuse and pressure lower leg
          • multiple sites - M70.89 Other soft tissue disorders related to use, overuse and pressure multiple sites
          • pelvic region - M70.85 Other soft tissue disorders related to use, overuse and pressure of thigh
          • shoulder region - M70.81 Other soft tissue disorders related to use, overuse and pressure of shoulder
          • specified site NEC - M70.88 Other soft tissue disorders related to use, overuse and pressure other site
          • thigh - M70.85 Other soft tissue disorders related to use, overuse and pressure of thigh
          • upper arm - M70.82 Other soft tissue disorders related to use, overuse and pressure of upper arm
        • thigh - M70.95 Unspecified soft tissue disorder related to use, overuse and pressure of thigh
        • upper arm - M70.92 Unspecified soft tissue disorder related to use, overuse and pressure of upper arm
      • foot - M79.9 Soft tissue disorder, unspecified
      • forearm - M79.9 Soft tissue disorder, unspecified
      • hand - M79.9 Soft tissue disorder, unspecified
      • lower leg - M79.9 Soft tissue disorder, unspecified
      • multiple sites - M79.9 Soft tissue disorder, unspecified
      • occupational - See: Disorder, soft tissue, due to use, overuse and pressure;
      • pelvic region - M79.9 Soft tissue disorder, unspecified
      • shoulder region - M79.9 Soft tissue disorder, unspecified
      • specified type NEC - M79.89 Other specified soft tissue disorders
      • thigh - M79.9 Soft tissue disorder, unspecified
      • upper arm - M79.9 Soft tissue disorder, unspecified
    • somatic symptom - F45.1 Undifferentiated somatoform disorder
    • somatization - F45.0 Somatization disorder
    • somatoform - F45.9 Somatoform disorder, unspecified
      • pain (persistent) - F45.41 Pain disorder exclusively related to psychological factors
      • somatization (multiple) (long-lasting) - F45.0 Somatization disorder
      • specified NEC - F45.8 Other somatoform disorders
      • undifferentiated - F45.1 Undifferentiated somatoform disorder
    • somnolence, excessive - See: Hypersomnia;
    • specific
      • arithmetical - F81.2 Mathematics disorder
      • developmental, of motor - F82 Specific developmental disorder of motor function
      • reading - F81.0 Specific reading disorder
      • speech and language - F80.9 Developmental disorder of speech and language, unspecified
      • spelling - F81.81 Disorder of written expression
      • written expression - F81.81 Disorder of written expression
    • speech - R47.9 Unspecified speech disturbances
      • articulation (functional) (specific) - F80.0 Phonological disorder
      • developmental - F80.9 Developmental disorder of speech and language, unspecified
      • specified NEC - R47.89 Other speech disturbances
    • speech-sound - F80.0 Phonological disorder
    • spelling (specific) - F81.81 Disorder of written expression
    • spine - See Also: Dorsopathy;
      • ligamentous or muscular attachments, peripheral - See: Enthesopathy, spinal;
      • specified NEC - See: Dorsopathy, specified NEC;
    • stereotyped, habit or movement - F98.4 Stereotyped movement disorders
    • stimulant use (other) (unspecified)
      • mild - F15.10 Other stimulant abuse, uncomplicated
        • in remission (early) (sustained) - F15.11 Other stimulant abuse, in remission
      • moderate or severe - F15.20 Other stimulant dependence, uncomplicated
        • in remission (early) (sustained) - F15.21 Other stimulant dependence, in remission
    • stomach (functional) - See: Disorder, gastric;
    • stress - F43.9 Reaction to severe stress, unspecified
      • acute - F43.0 Acute stress reaction
      • post-traumatic - F43.10 Post-traumatic stress disorder, unspecified
        • acute - F43.11 Post-traumatic stress disorder, acute
        • chronic - F43.12 Post-traumatic stress disorder, chronic
    • substance use (other) (unknown)
      • mild - F19.10 Other psychoactive substance abuse, uncomplicated
        • substance intoxication - F19.129 Other psychoactive substance abuse with intoxication, unspecified
        • substance intoxication delirium - F19.121 Other psychoactive substance abuse with intoxication delirium
        • with substance-induced
          • anxiety disorder - F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
          • depressive disorder - F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
          • major neurocognitive disorder - F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
          • mild neurocognitive disorder - F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder
          • sexual dysfunction - F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
      • moderate or severe - F19.20 Other psychoactive substance dependence, uncomplicated
        • in remission (early) (sustained) - F19.21 Other psychoactive substance dependence, in remission
        • substance intoxication - F19.229 Other psychoactive substance dependence with intoxication, unspecified
        • substance intoxication delirium - F19.221 Other psychoactive substance dependence with intoxication delirium
        • with substance-induced
          • anxiety disorder - F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
          • depressive disorder - F19.24 Other psychoactive substance dependence with psychoactive substance-induced mood disorder
          • major neurocognitive disorder - F19.27 Other psychoactive substance dependence with psychoactive substance-induced persisting dementia
          • mild neurocognitive disorder - F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder
          • sexual dysfunction - F19.281 Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
    • sulfur-bearing amino-acid metabolism - E72.10 Disorders of sulfur-bearing amino-acid metabolism, unspecified
    • sweat gland (eccrine) - L74.9 Eccrine sweat disorder, unspecified
      • apocrine - L75.9 Apocrine sweat disorder, unspecified
        • specified NEC - L75.8 Other apocrine sweat disorders
      • specified NEC - L74.8 Other eccrine sweat disorders
    • synovium - M67.90 Unspecified disorder of synovium and tendon, unspecified site
      • acromioclavicular - M67.91 Unspecified disorder of synovium and tendon, shoulder
      • ankle - M67.97 Unspecified disorder of synovium and tendon, ankle and foot
      • elbow - M67.92 Unspecified disorder of synovium and tendon, upper arm
      • foot - M67.97 Unspecified disorder of synovium and tendon, ankle and foot
      • forearm - M67.93 Unspecified disorder of synovium and tendon, forearm
      • hand - M67.94 Unspecified disorder of synovium and tendon, hand
      • hip - M67.95 Unspecified disorder of synovium and tendon, thigh
      • knee - M67.96 Unspecified disorder of synovium and tendon, lower leg
      • multiple sites - M67.99 Unspecified disorder of synovium and tendon, multiple sites
      • rupture - See: Rupture, synovium;
      • shoulder - M67.91 Unspecified disorder of synovium and tendon, shoulder
      • specified type NEC - M67.80 Other specified disorders of synovium and tendon, unspecified site
        • acromioclavicular - M67.81 Other specified disorders of synovium and tendon, shoulder
        • ankle - M67.87 Other specified disorders of synovium and tendon, ankle and foot
        • elbow - M67.82 Other specified disorders of synovium and tendon, elbow
        • foot - M67.87 Other specified disorders of synovium and tendon, ankle and foot
        • hand - M67.84 Other specified disorders of synovium and tendon, hand
        • hip - M67.85 Other specified disorders of synovium and tendon, hip
        • knee - M67.86 Other specified disorders of synovium and tendon, knee
        • multiple sites - M67.89 Other specified disorders of synovium and tendon, multiple sites
        • wrist - M67.83 Other specified disorders of synovium and tendon, wrist
      • synovitis - See: Synovitis;
      • upper arm - M67.92 Unspecified disorder of synovium and tendon, upper arm
      • wrist - M67.93 Unspecified disorder of synovium and tendon, forearm
    • temperature regulation, newborn - P81.9 Disturbance of temperature regulation of newborn, unspecified
      • specified NEC - P81.8 Other specified disturbances of temperature regulation of newborn
    • temporomandibular joint - M26.60 Temporomandibular joint disorder, unspecified
    • tendon - M67.90 Unspecified disorder of synovium and tendon, unspecified site
      • acromioclavicular - M67.91 Unspecified disorder of synovium and tendon, shoulder
      • ankle - M67.97 Unspecified disorder of synovium and tendon, ankle and foot
      • contracture - See: Contracture, tendon;
      • elbow - M67.92 Unspecified disorder of synovium and tendon, upper arm
      • foot - M67.97 Unspecified disorder of synovium and tendon, ankle and foot
      • forearm - M67.93 Unspecified disorder of synovium and tendon, forearm
      • hand - M67.94 Unspecified disorder of synovium and tendon, hand
      • hip - M67.95 Unspecified disorder of synovium and tendon, thigh
      • knee - M67.96 Unspecified disorder of synovium and tendon, lower leg
      • multiple sites - M67.99 Unspecified disorder of synovium and tendon, multiple sites
      • rupture - See: Rupture, tendon;
      • shoulder - M67.91 Unspecified disorder of synovium and tendon, shoulder
      • specified type NEC - M67.80 Other specified disorders of synovium and tendon, unspecified site
        • acromioclavicular - M67.81 Other specified disorders of synovium and tendon, shoulder
        • ankle - M67.87 Other specified disorders of synovium and tendon, ankle and foot
        • elbow - M67.82 Other specified disorders of synovium and tendon, elbow
        • foot - M67.87 Other specified disorders of synovium and tendon, ankle and foot
        • hand - M67.84 Other specified disorders of synovium and tendon, hand
        • hip - M67.85 Other specified disorders of synovium and tendon, hip
        • knee - M67.86 Other specified disorders of synovium and tendon, knee
        • multiple sites - M67.89 Other specified disorders of synovium and tendon, multiple sites
        • trunk - M67.88 Other specified disorders of synovium and tendon, other site
        • wrist - M67.83 Other specified disorders of synovium and tendon, wrist
      • synovitis - See: Synovitis;
      • tendinitis - See: Tendinitis;
      • tenosynovitis - See: Tenosynovitis;
      • trunk - M67.98 Unspecified disorder of synovium and tendon, other site
      • upper arm - M67.92 Unspecified disorder of synovium and tendon, upper arm
      • wrist - M67.93 Unspecified disorder of synovium and tendon, forearm
    • thoracic root (nerve) NEC - G54.3 Thoracic root disorders, not elsewhere classified
    • thyrocalcitonin hypersecretion - E07.0 Hypersecretion of calcitonin
    • thyroid (gland) - E07.9 Disorder of thyroid, unspecified
      • function NEC, neonatal, transitory - P72.2 Other transitory neonatal disorders of thyroid function, not elsewhere classified
      • specified NEC - E07.89 Other specified disorders of thyroid
    • tic - See: Tic;
    • tobacco use
      • chewing tobacco (mild) (moderate) (severe)
        • in remission (early) (sustained) - F17.221 Nicotine dependence, chewing tobacco, in remission
      • cigarettes (mild) (moderate) (severe)
        • in remission (early) (sustained) - F17.211 Nicotine dependence, cigarettes, in remission
      • mild - F17.200 Nicotine dependence, unspecified, uncomplicated
        • in remission (early) (sustained) - F17.201 Nicotine dependence, unspecified, in remission
      • moderate - F17.200 Nicotine dependence, unspecified, uncomplicated
        • in remission (early) (sustained) - F17.201 Nicotine dependence, unspecified, in remission
      • severe - F17.200 Nicotine dependence, unspecified, uncomplicated
        • in remission (early) (sustained) - F17.201 Nicotine dependence, unspecified, in remission
      • specified product NEC (mild) (moderate) (severe)
        • in remission (early) (sustained) - F17.291 Nicotine dependence, other tobacco product, in remission
    • tooth - K08.9 Disorder of teeth and supporting structures, unspecified
      • development - K00.9 Disorder of tooth development, unspecified
        • specified NEC - K00.8 Other disorders of tooth development
      • eruption - K00.6 Disturbances in tooth eruption
    • Tourette's - F95.2 Tourette's disorder
    • trance and possession - F44.89 Other dissociative and conversion disorders
    • transvestic - F65.1 Transvestic fetishism
    • tricuspid (valve) - See: Endocarditis, tricuspid;
    • tryptophan metabolism - E70.5 Disorders of tryptophan metabolism
    • tubular, phosphate-losing - N25.0 Renal osteodystrophy
    • tubulo-interstitial (in)
      • brucellosis - A23.9 Brucellosis, unspecified
      • cystinosis - E72.04 Cystinosis
      • diphtheria - A36.84 Diphtheritic tubulo-interstitial nephropathy
      • glycogen storage disease - E74.00 Glycogen storage disease, unspecified
      • leukemia NEC - C95.9 Leukemia, unspecified
      • lymphoma NEC - C85.9 Non-Hodgkin lymphoma, unspecified
      • mixed cryoglobulinemia - D89.1 Cryoglobulinemia
      • multiple myeloma - C90.0 Multiple myeloma
      • Salmonella infection - A02.25 Salmonella pyelonephritis
      • sarcoidosis - D86.84 Sarcoid pyelonephritis
      • sepsis - A41.9 Sepsis, unspecified organism
        • streptococcal - A40.9 Streptococcal sepsis, unspecified
      • systemic lupus erythematosus - M32.15 Tubulo-interstitial nephropathy in systemic lupus erythematosus
      • toxoplasmosis - B58.83 Toxoplasma tubulo-interstitial nephropathy
      • transplant rejection - T86.91 Unspecified transplanted organ and tissue rejection
      • Wilson's disease - E83.01 Wilson's disease
    • tubulo-renal function, impaired - N25.9 Disorder resulting from impaired renal tubular function, unspecified
      • specified NEC - N25.89 Other disorders resulting from impaired renal tubular function
    • tympanic membrane - H73.9 Unspecified disorder of tympanic membrane
      • atrophy - See: Atrophy, tympanic membrane;
      • infection - See: Myringitis;
      • perforation - See: Perforation, tympanum;
      • specified NEC - H73.89 Other specified disorders of tympanic membrane
    • unsocialized aggressive - F91.1 Conduct disorder, childhood-onset type
    • urea cycle metabolism - E72.20 Disorder of urea cycle metabolism, unspecified
      • argininemia - E72.21 Argininemia
      • arginosuccinic aciduria - E72.22 Arginosuccinic aciduria
      • citrullinemia - E72.23 Citrullinemia
      • ornithine transcarbamylase deficiency - E72.4 Disorders of ornithine metabolism
      • other specified - E72.29 Other disorders of urea cycle metabolism
    • ureter (in) - N28.9 Disorder of kidney and ureter, unspecified
      • schistosomiasis - B65.0 Schistosomiasis due to Schistosoma haematobium [urinary schistosomiasis]
      • tuberculosis - A18.11 Tuberculosis of kidney and ureter
    • urethra - N36.9 Urethral disorder, unspecified
      • specified NEC - N36.8 Other specified disorders of urethra
    • urinary system - N39.9 Disorder of urinary system, unspecified
      • specified NEC - N39.8 Other specified disorders of urinary system
    • valve, heart
      • aortic - See: Endocarditis, aortic;
      • mitral - See: Endocarditis, mitral;
      • pulmonary - See: Endocarditis, pulmonary;
      • rheumatic
        • aortic - See: Endocarditis, aortic, rheumatic;
        • mitral - See: Endocarditis, mitral;
        • pulmonary - See: Endocarditis, pulmonary, rheumatic;
        • tricuspid - See: Endocarditis, tricuspid;
      • tricuspid - See: Endocarditis, tricuspid;
    • vestibular function - H81.9 Unspecified disorder of vestibular function
      • specified NEC
        • in diseases classified elsewhere - H82.
      • vertigo - See: Vertigo;
    • vision, binocular - H53.30 Unspecified disorder of binocular vision
      • abnormal retinal correspondence - H53.31 Abnormal retinal correspondence
      • diplopia - H53.2 Diplopia
      • fusion with defective stereopsis - H53.32 Fusion with defective stereopsis
      • simultaneous perception - H53.33 Simultaneous visual perception without fusion
      • suppression - H53.34 Suppression of binocular vision
    • visual
      • cortex
        • blindness - H47.619 Cortical blindness, unspecified side of brain
          • left brain - H47.612 Cortical blindness, left side of brain
          • right brain - H47.611 Cortical blindness, right side of brain
        • due to
          • inflammatory disorder - H47.629 Disorders of visual cortex in (due to) inflammatory disorders, unspecified side of brain
            • left brain - H47.622 Disorders of visual cortex in (due to) inflammatory disorders, left side of brain
            • right brain - H47.621 Disorders of visual cortex in (due to) inflammatory disorders, right side of brain
          • neoplasm - H47.639 Disorders of visual cortex in (due to) neoplasm, unspecified side of brain
            • left brain - H47.632 Disorders of visual cortex in (due to) neoplasm, left side of brain
            • right brain - H47.631 Disorders of visual cortex in (due to) neoplasm, right side of brain
          • vascular disorder - H47.649 Disorders of visual cortex in (due to) vascular disorders, unspecified side of brain
            • left brain - H47.642 Disorders of visual cortex in (due to) vascular disorders, left side of brain
            • right brain - H47.641 Disorders of visual cortex in (due to) vascular disorders, right side of brain
      • pathway - H47.9 Unspecified disorder of visual pathways
        • due to
          • inflammatory disorder - H47.51 Disorders of visual pathways in (due to) inflammatory disorders
          • neoplasm - H47.52 Disorders of visual pathways in (due to) neoplasm
          • vascular disorder - H47.53 Disorders of visual pathways in (due to) vascular disorders
        • optic chiasm - See: Disorder, optic, chiasm;
    • vitreous body - H43.9 Unspecified disorder of vitreous body
      • crystalline deposits - See: Deposit, crystalline;
      • degeneration - See: Degeneration, vitreous;
      • hemorrhage - See: Hemorrhage, vitreous;
      • opacities - See: Opacity, vitreous;
      • prolapse - See: Prolapse, vitreous;
      • specified type NEC - H43.89 Other disorders of vitreous body
    • voice - R49.9 Unspecified voice and resonance disorder
      • specified type NEC - R49.8 Other voice and resonance disorders
    • volatile solvent use
      • due to drug abuse - See: Abuse, drug, inhalant;
      • due to drug dependence - See: Dependence, drug, inhalant;
    • voyeuristic - F65.3 Voyeurism
    • white blood cells - D72.9 Disorder of white blood cells, unspecified
      • specified NEC - D72.89 Other specified disorders of white blood cells
    • withdrawing, child or adolescent - F40.10 Social phobia, unspecified

Clinical Terms

The following are some of the clinical term definitions related or applicable to disorder (of) within the ICD-10 index for Diseases and Injuries.

Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.

Acoustics: The branch of physics that deals with sound and sound waves. In medicine it is often applied in procedures in speech and hearing studies. With regard to the environment, it refers to the characteristics of a room, auditorium, theatre, building, etc. that determines the audibility or fidelity of sounds in it. (From Random House Unabridged Dictionary, 2d ed)

Adhesives: Substances that cause the adherence of two surfaces. They include glues (properly collagen-derived adhesives), mucilages, sticky pastes, gums, resins, or latex.

Adolescent: A person 13 to 18 years of age.

Albinism: General term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.

Amphetamines: Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Anisometropia: A condition of an inequality of refractive power of the two eyes.

Ankle: The region of the lower limb between the FOOT and the LEG.

Anorexia: The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA.

Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Anxiety Disorders: Persistent and disabling ANXIETY.

Anti-Anxiety Agents: Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Aortic Valve: The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle.

Aphakia: Absence of crystalline lens totally or partially from field of vision, from any cause except after cataract extraction. Aphakia is mainly congenital or as result of LENS DISLOCATION AND SUBLUXATION.

Appetite: Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS.

Astigmatism: Unequal curvature of the refractive surfaces of the eye. Thus a point source of light cannot be brought to a point focus on the retina but is spread over a more or less diffuse area. This results from the radius of curvature in one plane being longer or shorter than the radius at right angles to it. (Dorland, 27th ed)

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Autonomic Nervous System: The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.

Bilirubin: A bile pigment that is a degradation product of HEME.

Blepharophimosis: The abnormal narrowness of the palpebral fissure in the horizontal direction caused by the lateral displacement of the medial canthi of the eyelids. (Dorland, 27th ed)

Blepharoptosis: Drooping of the upper lid due to deficient development or paralysis of the levator palpebrae muscle.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Blood: The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.

Bone and Bones: A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.

Brachial Plexus: The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon.

Breast: In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.

Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.

Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger".

Bursitis: Inflammation or irritation of a SYNOVIAL BURSA, the fibrous sac that acts as a cushion between moving structures of bones, muscles, tendons or skin.

Caffeine: A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling.

Calcium: A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.

Cannabis: The plant genus in the Cannabaceae plant family, Urticales order, Hamamelidae subclass. The flowering tops are called many slang terms including pot, marijuana, hashish, bhang, and ganja. The stem is an important source of hemp fiber.

Carbohydrates: A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES.

Cartilage: A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Cellulitis: An acute, diffuse, and suppurative inflammation of loose connective tissue, particularly the deep subcutaneous tissues, and sometimes muscle, which is most commonly seen as a result of infection of a wound, ulcer, or other skin lesions.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Child: A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.

Chondrocalcinosis: Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.

Choroid: The thin, highly vascular membrane covering most of the posterior of the eye between the RETINA and SCLERA.

Ciliary Body: A ring of tissue extending from the scleral spur to the ora serrata of the RETINA. It consists of the uveal portion and the epithelial portion. The ciliary muscle is in the uveal portion and the ciliary processes are in the epithelial portion.

Circadian Rhythm: The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli.

Citrullinemia: A group of diseases related to a deficiency of the enzyme ARGININOSUCCINATE SYNTHASE which causes an elevation of serum levels of CITRULLINE. In neonates, clinical manifestations include lethargy, hypotonia, and SEIZURES. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ATAXIA, behavioral changes, and DYSARTHRIA. (From Menkes, Textbook of Child Neurology, 5th ed, p49)

Clavicle: A bone on the ventral side of the shoulder girdle, which in humans is commonly called the collar bone.

Cocaine: An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake.

Coloboma: Congenital anomaly in which some of the structures of the eye are absent due to incomplete fusion of the fetal intraocular fissure during gestation.

Communication: The exchange or transmission of ideas, attitudes, or beliefs between individuals or groups.

Conjunctiva: The mucous membrane that covers the posterior surface of the eyelids and the anterior pericorneal surface of the eyeball.

Contracture: Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.

Copper: A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55.

Cornea: The transparent anterior portion of the fibrous coat of the eye consisting of five layers: stratified squamous CORNEAL EPITHELIUM; BOWMAN MEMBRANE; CORNEAL STROMA; DESCEMET MEMBRANE; and mesenchymal CORNEAL ENDOTHELIUM. It serves as the first refracting medium of the eye. It is structurally continuous with the SCLERA, avascular, receiving its nourishment by permeation through spaces between the lamellae, and is innervated by the ophthalmic division of the TRIGEMINAL NERVE via the ciliary nerves and those of the surrounding conjunctiva which together form plexuses. (Cline et al., Dictionary of Visual Science, 4th ed)

Cranial Nerves: Twelve pairs of nerves that carry general afferent, visceral afferent, special afferent, somatic efferent, and autonomic efferent fibers.

Cryoglobulinemia: A condition characterized by the presence of abnormal quantities of CRYOGLOBULINS in the blood. Upon cold exposure, these abnormal proteins precipitate into the microvasculature leading to restricted blood flow in the exposed areas.

Cysts: Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.

Cystinosis: A metabolic disease characterized by the defective transport of CYSTINE across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the KIDNEY, nephropathic cystinosis is a common cause of RENAL FANCONI SYNDROME.

Cystinuria: An inherited disorder due to defective reabsorption of CYSTINE and other BASIC AMINO ACIDS by the PROXIMAL RENAL TUBULES. This form of aminoaciduria is characterized by the abnormally high urinary levels of cystine; LYSINE; ARGININE; and ORNITHINE. Mutations involve the amino acid transport protein gene SLC3A1.

Deafness: A general term for the complete loss of the ability to hear from both ears.

Congenital Abnormalities: Malformations of organs or body parts during development in utero.

Delirium: A disorder characterized by CONFUSION; inattentiveness; disorientation; ILLUSIONS; HALLUCINATIONS; agitation; and in some instances autonomic nervous system overactivity. It may result from toxic/metabolic conditions or structural brain lesions. (From Adams et al., Principles of Neurology, 6th ed, pp411-2)

Delusions: A false belief regarding the self or persons or objects outside the self that persists despite the facts, and is not considered tenable by one's associates.

Depersonalization: State in which an individual perceives or experiences a sensation of unreality concerning the self or the environment; it is seen in disorders such as schizophrenia, affection disorders, organic mental disorders, and personality disorders. (APA, Thesaurus of Psychological Index Terms, 8th ed.)

Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.

Diaphragm: The musculofibrous partition that separates the THORACIC CAVITY from the ABDOMINAL CAVITY. Contraction of the diaphragm increases the volume of the thoracic cavity aiding INHALATION.

Diphtheria: A localized infection of mucous membranes or skin caused by toxigenic strains of CORYNEBACTERIUM DIPHTHERIAE. It is characterized by the presence of a pseudomembrane at the site of infection. DIPHTHERIA TOXIN, produced by C. diphtheriae, can cause myocarditis, polyneuritis, and other systemic toxic effects.

Diplopia: A visual symptom in which a single object is perceived by the visual cortex as two objects rather than one. Disorders associated with this condition include REFRACTIVE ERRORS; STRABISMUS; OCULOMOTOR NERVE DISEASES; TROCHLEAR NERVE DISEASES; ABDUCENS NERVE DISEASES; and diseases of the BRAIN STEM and OCCIPITAL LOBE.

Displacement (Psychology): The process by which an emotional or behavioral response that is appropriate for one situation appears in another situation for which it is inappropriate.

Problem Behavior: Troublesome or disruptive behavioral displays.

Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.

Dry Eye Syndromes: Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur.

Ear: The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE.

Edema: Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE.

Elbow: Region of the body immediately surrounding and including the ELBOW JOINT.

Elephantiasis: Hypertrophy and thickening of tissues from causes other than filarial infection, the latter being described as ELEPHANTIASIS, FILARIAL.

Endophthalmitis: Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.

Enophthalmos: Recession of the eyeball into the orbit.

Esophagus: The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.

Eustachian Tube: A narrow passageway that connects the upper part of the throat to the TYMPANIC CAVITY.

Exophthalmos: Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.

Exostoses: Benign hypertrophy that projects outward from the surface of bone, often containing a cartilaginous component.

Eye: The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.

Eyelids: Each of the upper and lower folds of SKIN which cover the EYE when closed.

Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.

Female:

Femur: The longest and largest bone of the skeleton, it is situated between the hip and the knee.

Fibula: The bone of the lower leg lateral to and smaller than the tibia. In proportion to its length, it is the most slender of the long bones.

Fingers: Four or five slender jointed digits in humans and primates, attached to each HAND.

Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.

Foot: The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones.

Foot Joints: The articulations extending from the ANKLE distally to the TOES. These include the ANKLE JOINT; TARSAL JOINTS; METATARSOPHALANGEAL JOINT; and TOE JOINT.

Forearm: Part of the upper extremity in humans and primates extending from the ELBOW to the WRIST.

Fructose: A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding.

Galactorrhea: Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.

Galactose: An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood.

Gambling: An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money.

Gluconeogenesis: Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.

Glutamine: A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells.

Glycine: A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter.

Glycogen Storage Disease: A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.

Glycoproteins: Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins.

Granuloma: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.

Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.

Hand: The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb.

Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.

Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.

Hemorrhage: Bleeding or escape of blood from a vessel.

Hemostasis: The process which spontaneously arrests the flow of BLOOD from vessels carrying blood under pressure. It is accomplished by contraction of the vessels, adhesion and aggregation of formed blood elements (eg. ERYTHROCYTE AGGREGATION), and the process of BLOOD COAGULATION.

Hip: The projecting part on each side of the body, formed by the side of the pelvis and the top portion of the femur.

Histidine: An essential amino acid that is required for the production of HISTAMINE.

Hoarding: A persistent difficulty discarding or parting with possessions.

Homocystinuria: Autosomal recessive inborn error of methionine metabolism usually caused by a deficiency of CYSTATHIONINE BETA-SYNTHASE and associated with elevations of homocysteine in plasma and urine. Clinical features include a tall slender habitus, SCOLIOSIS, arachnodactyly, MUSCLE WEAKNESS, genu varus, thin blond hair, malar flush, lens dislocations, an increased incidence of MENTAL RETARDATION, and a tendency to develop fibrosis of arteries, frequently complicated by CEREBROVASCULAR ACCIDENTS and MYOCARDIAL INFARCTION. (From Adams et al., Principles of Neurology, 6th ed, p979)

Humerus: Bone in humans and primates extending from the SHOULDER JOINT to the ELBOW JOINT.

Hydroxylysine: A hydroxylated derivative of the amino acid LYSINE that is present in certain collagens.

Hypercalcemia: Abnormally high level of calcium in the blood.

Hyperoxaluria: Excretion of an excessive amount of OXALATES in the urine.

Hypertrichosis: Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.

Hypnotics and Sedatives: Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)

Hypophosphatasia: A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)

Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.

Ilium: The largest of three bones that make up each half of the pelvic girdle.

Infection: Invasion of the host organism by microorganisms that can cause pathological conditions or diseases.

Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.

Iris: The most anterior portion of the uveal layer, separating the anterior chamber from the posterior. It consists of two layers - the stroma and the pigmented epithelium. Color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium.

Iron: A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.

Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.

Ischium: One of three bones that make up the coxal bone of the pelvic girdle. In tetrapods, it is the part of the pelvis that projects backward on the ventral side, and in primates, it bears the weight of the sitting animal.

Isoleucine: An essential branched-chain aliphatic amino acid found in many proteins. It is an isomer of LEUCINE. It is important in hemoglobin synthesis and regulation of blood sugar and energy levels.

Joints: Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed.

Keratitis: Inflammation of the cornea.

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Kidney: Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.

Knee: A region of the lower extremity immediately surrounding and including the KNEE JOINT.

Lactation: The processes of milk secretion by the maternal MAMMARY GLANDS after PARTURITION. The proliferation of the mammary glandular tissue, milk synthesis, and milk expulsion or let down are regulated by the interactions of several hormones including ESTRADIOL; PROGESTERONE; PROLACTIN; and OXYTOCIN.

Language: A verbal or nonverbal means of communicating ideas or feelings.

Learning: Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge.

Leucine: An essential branched-chain amino acid important for hemoglobin formation.

Ligaments: Shiny, flexible bands of fibrous tissue connecting together articular extremities of bones. They are pliant, tough, and inextensile.

Extremities: The farthest or outermost projections of the body, such as the HAND and FOOT.

Lipoproteins: Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes.

Liver: A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances.

Lower Extremity: The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.

Lumbosacral Region: Region of the back including the LUMBAR VERTEBRAE, SACRUM, and nearby structures.

Lysine: An essential amino acid. It is often added to animal feed.

Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.

Magnesium: A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.

Male:

Maple Syrup Urine Disease: An autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (AMINO ACIDS, BRANCHED-CHAIN). These metabolites accumulate in body fluids and render a "maple syrup" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (From Adams et al., Principles of Neurology, 6th ed, p936)

Mastitis: INFLAMMATION of the BREAST, or MAMMARY GLAND.

Mastoid: The posterior part of the temporal bone. It is a projection of the petrous bone.

Mathematics: The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)

Membranes: Thin layers of tissue which cover parts of the body, separate adjacent cavities, or connect adjacent structures.

Meniscus: Crescent-shaped cartilaginous tissue interposed between two articulating bones.

Metabolism: The chemical reactions in living organisms by which energy is provided for vital processes and activities and new material is assimilated.

Metacarpus: The region of the HAND between the WRIST and the FINGERS.

Metatarsus: The part of the foot between the tarsa and the TOES.

Mood Disorders: Those disorders that have a disturbance in mood as their predominant feature.

Movement: The act, process, or result of passing from one place or position to another. It differs from LOCOMOTION in that locomotion is restricted to the passing of the whole body from one place to another, while movement encompasses both locomotion but also a change of the position of the whole body or any of its parts. Movement may be used with reference to humans, vertebrate and invertebrate animals, and microorganisms. Differentiate also from MOTOR ACTIVITY, movement associated with behavior.

Mucopolysaccharidoses: Group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.

Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.

Dissociative Identity Disorder: A dissociative disorder in which the individual adopts two or more distinct personalities. Each personality is a fully integrated and complex unit with memories, behavior patterns and social friendships. Transition from one personality to another is sudden.

Mumps: An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed)

Muscles: Contractile tissue that produces movement in animals.

Muscular Diseases: Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.

Myopia: A refractive error in which rays of light entering the EYE parallel to the optic axis are brought to a focus in front of the RETINA when accommodation (ACCOMMODATION, OCULAR) is relaxed. This results from an overly curved CORNEA or from the eyeball being too long from front to back. It is also called nearsightedness.

Neck: The part of a human or animal body connecting the HEAD to the rest of the body.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Nervous System: The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)

Infant, Newborn: An infant during the first 28 days after birth.

Nose: A part of the upper respiratory tract. It contains the organ of SMELL. The term includes the external nose, the nasal cavity, and the PARANASAL SINUSES.

Optic Chiasm: The X-shaped structure formed by the meeting of the two optic nerves. At the optic chiasm the fibers from the medial part of each retina cross to project to the other side of the brain while the lateral retinal fibers continue on the same side. As a result each half of the brain receives information about the contralateral visual field from both eyes.

Orbit: Bony cavity that holds the eyeball and its associated tissues and appendages.

Ornithine: An amino acid produced in the urea cycle by the splitting off of urea from arginine.

Osteophyte: Bony outgrowth usually found around joints and often seen in conditions such as ARTHRITIS.

Otitis: Inflammation of the ear, which may be marked by pain (EARACHE), fever, HEARING DISORDERS, and VERTIGO. Inflammation of the external ear is OTITIS EXTERNA; of the middle ear, OTITIS MEDIA; of the inner ear, LABYRINTHITIS.

Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.

Panic: A state of extreme acute, intense anxiety and unreasoning fear accompanied by disorganization of personality function.

Patella: The flat, triangular bone situated at the anterior part of the KNEE.

Pelvis: The space or compartment surrounded by the pelvic girdle (bony pelvis). It is subdivided into the greater pelvis and LESSER PELVIS. The pelvic girdle is formed by the PELVIC BONES and SACRUM.

Penis: The external reproductive organ of males. It is composed of a mass of erectile tissue enclosed in three cylindrical fibrous compartments. Two of the three compartments, the corpus cavernosa, are placed side-by-side along the upper part of the organ. The third compartment below, the corpus spongiosum, houses the urethra.

Personality: Behavior-response patterns that characterize the individual.

Phencyclidine: A hallucinogen formerly used as a veterinary anesthetic, and briefly as a general anesthetic for humans. Phencyclidine is similar to KETAMINE in structure and in many of its effects. Like ketamine, it can produce a dissociative state. It exerts its pharmacological action through inhibition of NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE). As a drug of abuse, it is known as PCP and Angel Dust.

Phosphorus: A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.

Pica: The persistent eating of non-nutritive substances for a period of at least one month.

Pigmentation: Coloration or discoloration of a part by a pigment.

Pituitary Gland: A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.

Polyps: Discrete abnormal tissue masses that protrude into the lumen of the DIGESTIVE TRACT or the RESPIRATORY TRACT. Polyps can be spheroidal, hemispheroidal, or irregular mound-shaped structures attached to the MUCOUS MEMBRANE of the lumen wall either by a stalk, pedunculus, or by a broad base.

Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.

Prolapse: The protrusion of an organ or part of an organ into a natural or artificial orifice.

Propionic Acidemia: Autosomal recessive metabolic disorder caused by mutations in PROPIONYL-COA CARBOXYLASE genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. Neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, HYPERGLYCEMIA, lethargy, vomiting, HYPOTONIA; and HEPATOMEGALY. Survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. Late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.

Prostate: A gland in males that surrounds the neck of the URINARY BLADDER and the URETHRA. It secretes a substance that liquefies coagulated semen. It is situated in the pelvic cavity behind the lower part of the PUBIC SYMPHYSIS, above the deep layer of the triangular ligament, and rests upon the RECTUM.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Puberty: A period in the human life in which the development of the hypothalamic-pituitary-gonadal system takes place and reaches full maturity. The onset of synchronized endocrine events in puberty lead to the capacity for reproduction (FERTILITY), development of secondary SEX CHARACTERISTICS, and other changes seen in ADOLESCENT DEVELOPMENT.

Radiculopathy: Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.

Radius: The outer shorter of the two bones of the FOREARM, lying parallel to the ULNA and partially revolving around it.

Reading: Acquiring information from text.

Reflex: An involuntary movement or exercise of function in a part, excited in response to a stimulus applied to the periphery and transmitted to the brain or spinal cord.

Retina: The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.

Ribs: A set of twelve curved bones which connect to the vertebral column posteriorly, and terminate anteriorly as costal cartilage. Together, they form a protective cage around the internal thoracic organs.

Rupture: Forcible or traumatic tear or break of an organ or other soft part of the body.

Sacrococcygeal Region: The body region between (and flanking) the SACRUM and COCCYX.

Salmonella Infections: Infections with bacteria of the genus SALMONELLA.

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Scapula: Also called the shoulder blade, it is a flat triangular bone, a pair of which form the back part of the shoulder girdle.

Cicatrix: The fibrous tissue that replaces normal tissue during the process of WOUND HEALING.

Schistosomiasis: Infection with flukes (trematodes) of the genus SCHISTOSOMA. Three species produce the most frequent clinical diseases: SCHISTOSOMA HAEMATOBIUM (endemic in Africa and the Middle East), SCHISTOSOMA MANSONI (in Egypt, northern and southern Africa, some West Indies islands, northern 2/3 of South America), and SCHISTOSOMA JAPONICUM (in Japan, China, the Philippines, Celebes, Thailand, Laos). S. mansoni is often seen in Puerto Ricans living in the United States.

Bodily Secretions: Endogenous substances produced through the activity of intact cells of glands, tissues, or organs.

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or "seizure disorder."

Sensation: The process in which specialized SENSORY RECEPTOR CELLS transduce peripheral stimuli (physical or chemical) into NERVE IMPULSES which are then transmitted to the various sensory centers in the CENTRAL NERVOUS SYSTEM.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.

Shoulder: Part of the body in humans and primates where the arms connect to the trunk. The shoulder has five joints; ACROMIOCLAVICULAR joint, CORACOCLAVICULAR joint, GLENOHUMERAL joint, scapulathoracic joint, and STERNOCLAVICULAR joint.

Siderosis: A form of pneumoconiosis resulting from inhalation of iron in the mining dust or welding fumes.

Skin: The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Skull: The SKELETON of the HEAD including the FACIAL BONES and the bones enclosing the BRAIN.

Sleep: A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.

Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.

Sodium: A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23.

Speech: Communication through a system of conventional vocal symbols.

Spine: The spinal or vertebral column.

Stomach: An organ of digestion situated in the left upper quadrant of the abdomen between the termination of the ESOPHAGUS and the beginning of the DUODENUM.

Strongyloidiasis: Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.

Endocarditis, Subacute Bacterial: ENDOCARDIUM infection that is usually caused by STREPTOCOCCUS. Subacute infective endocarditis evolves over weeks and months with modest toxicity and rare metastatic infection.

Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.

Synovitis: Inflammation of the SYNOVIAL MEMBRANE.

Syphilis: A contagious venereal disease caused by the spirochete TREPONEMA PALLIDUM.

Telangiectasis: Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders.

Temporomandibular Joint: An articulation between the condyle of the mandible and the articular tubercle of the temporal bone.

Tendons: Fibrous bands or cords of CONNECTIVE TISSUE at the ends of SKELETAL MUSCLE FIBERS that serve to attach the MUSCLES to bones and other structures.

Tenosynovitis: Inflammation of the synovial lining of a tendon sheath. Causes include trauma, tendon stress, bacterial disease (gonorrhea, tuberculosis), rheumatic disease, and gout. Common sites are the hand, wrist, shoulder capsule, hip capsule, hamstring muscles, and Achilles tendon. The tendon sheaths become inflamed and painful, and accumulate fluid. Joint mobility is usually reduced.

Thigh: The portion of the leg in humans and other animals found between the HIP and KNEE.

Threonine: An essential amino acid occurring naturally in the L-form, which is the active form. It is found in eggs, milk, gelatin, and other proteins.

Tibia: The second longest bone of the skeleton. It is located on the medial side of the lower leg, articulating with the FIBULA laterally, the TALUS distally, and the FEMUR proximally.

Tics: Habitual, repeated, rapid contraction of certain muscles, resulting in stereotyped individualized actions that can be voluntarily suppressed for only brief periods. They often involve the face, vocal cords, neck, and less often the extremities. Examples include repetitive throat clearing, vocalizations, sniffing, pursing the lips, and excessive blinking. Tics tend to be aggravated by emotional stress. When frequent they may interfere with speech and INTERPERSONAL RELATIONS. Conditions which feature frequent and prominent tics as a primary manifestation of disease are referred to as TIC DISORDERS. (From Adams et al., Principles of Neurology, 6th ed, pp109-10)

Tobacco Use: Use of TOBACCO (Nicotiana tabacum L) and TOBACCO PRODUCTS.

Toes: Any one of five terminal digits of the vertebrate FOOT.

Tooth: One of a set of bone-like structures in the mouth used for biting and chewing.

Toxoplasmosis: The acquired form of infection by Toxoplasma gondii in animals and man.

Tryptophan: An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals.

Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.

Tympanic Membrane: An oval semitransparent membrane separating the external EAR CANAL from the tympanic cavity (EAR, MIDDLE). It contains three layers: the skin of the external ear canal; the core of radially and circularly arranged collagen fibers; and the MUCOSA of the middle ear.

Tyrosine: A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin.

Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.

Ulna: The inner and longer bone of the FOREARM.

Arm: The superior part of the upper extremity between the SHOULDER and the ELBOW.

Upper Extremity: The region of the upper limb in animals, extending from the deltoid region to the HAND, and including the ARM; AXILLA; and SHOULDER.

Urethra: A tube that transports URINE from the URINARY BLADDER to the outside of the body in both the sexes. It also has a reproductive function in the male by providing a passage for SPERM.

Valine: A branched-chain essential amino acid that has stimulant activity. It promotes muscle growth and tissue repair. It is a precursor in the penicillin biosynthetic pathway.

Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.

Spine: The spinal or vertebral column.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.

Vitreous Body: The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.

Voice: The sounds produced by humans by the passage of air through the LARYNX and over the VOCAL CORDS, and then modified by the resonance organs, the NASOPHARYNX, and the MOUTH.

Walking: An activity in which the body advances at a slow to moderate pace by moving the feet in a coordinated fashion. This includes recreational walking, walking for fitness, and competitive race-walking.

Granulomatosis with Polyangiitis: A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN.

Wrist: The region of the upper limb between the metacarpus and the FOREARM.

Zellweger Syndrome: An autosomal recessive disorder due to defects in PEROXISOME biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; MUSCLE HYPOTONIA; SENSORINEURAL HEARING LOSS; visual compromise; SEIZURES; progressive degeneration of the KIDNEYS and the LIVER. Zellweger-like syndrome refers to phenotypes resembling the neonatal Zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.

Zinc: A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.